Assessing Health Care Resource Utilization And Costs Among Us Veterans Diagnosed With Asthma (English)
- New search for: Ogbomo, A.
- New search for: Tan, H.
- New search for: Kariburyo, M.
- New search for: Xie, L.
- New search for: Baser, O.
- New search for: Ogbomo, A.
- New search for: Tan, H.
- New search for: Kariburyo, M.
- New search for: Xie, L.
- New search for: Baser, O.
In:
VALUE IN HEALTH
;
19
, 3
;
A114-
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Assessing Health Care Resource Utilization And Costs Among Us Veterans Diagnosed With Asthma
-
Contributors:Ogbomo, A. ( author ) / Tan, H. ( author ) / Kariburyo, M. ( author ) / Xie, L. ( author ) / Baser, O. ( author )
-
Published in:VALUE IN HEALTH ; 19, 3 ; A114-
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2016-01-01
-
Size:A114-
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 19, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A1
-
Assessing Prescription Drug Value In The United States: A Hypothetical Example Comparing Asco And Icer Framework OutcomesBozkaya, D. / Migliaccio-Walle, K. / O’Day, K. et al. | 2016
- A1
-
Return on investment of a digital lifestyle management program in a medicare populationSu, W. / Chen, F. / Dall, T. / Becker, S. / Castro Sweet, C. / Payne, M. et al. | 2016
- A1
-
Estimating The Costs Of Supporting Safety-Net Transformation Into Patient-Centered Medical Homes In Post-Katrina New OrleansShao, H. / Shi, L. / Diana, M. / Brown, L. / Mason, K. / Cocran, D. / Carruth, A. / Schmidt, L. et al. | 2016
- A1
-
Comparative Effectiveness of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Among Elderly Medicare Beneficiaries In Terms Of Cost And Resource UseShah, R. / Yang, Y. / Bentley, J. P. / Banahan, B. et al. | 2016
- A2
-
Effectiveness And Safety Of Reduced Dose Non-Vitamin K Antagonist Oral Anticoagulants In Patients Without Severe Renal ImpairmentYao, X. / Shah, N. D. / Sangaralingham, L. R. / Gersh, B. J. et al. | 2016
- A2
-
Comparative Effectiveness of Panitumumab Versus Cetuximab In Patients With Chemo-Refractory Wild-Type Kras Metastatic Colorectal CancerXu, Y. / Hay, J. W. / Barzi, A. et al. | 2016
- A2
-
Bayesian Network Meta-Analysis To Assess Comparative Effectiveness of Beta-Blockers In Patients With Heart Failure And Reduced Ejection FractionAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2016
- A2
-
How Lipid-Lowering Therapy Impacts Lipid Abnormalities Among ACS Patients In Hong Kong Hospital—A Retrospective StudyLee, V. W. / Wang, Y. / Nichol, M. B. / Qu, L. L. / Cheng, T. C. / Yan, B. P. et al. | 2016
- A2
-
Comparative Cost And Resource Utilization In Hospitalized Patients Treated With Unfractionated Heparin MonITORED By Anti-XA or APTTCraver, C. W. / Belk, K. / Verma, K. et al. | 2016
- A2
-
Select Resource Utilization During Advanced Renal Cell Carcinoma Treatment: Comparison Of Targeted Drug ClassesFeinberg, B. A. / Garofalo, D. F. / Drenning, J. et al. | 2016
- A3
-
Comparing Health Care Utilization Among Three Treatment Regimens Provided To Commercially-Insured Patients With Chronic Hepatitis C Virus Genotype 1Kim, S. / Parente, A. et al. | 2016
- A3
-
Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United StatesGandra, S. R. / Villa, G. / Fonarow, G. / Lothgren, M. / Lindgren, P. / Somaratne, R. / van Hout, B. et al. | 2016
- A3
-
Medicare Part D Cost Sharing And Specialty Drug Initiation In Newly Diagnosed Chronic Myeloid Leukemia PatientsDoshi, J. A. / Li, P. / Huo, H. / Pettit, A. R. / Kumar, R. / Huntington, S. F. / Weiss, B. M. et al. | 2016
- A3
-
Utilization Patterns of Lipid-Lowering Medications In High Risk Diabetic PatientsVadhariya, A. / Aparasu, R. et al. | 2016
- A3
-
Potentially Inappropriate Antidepressant Use Among Older Adults In Office-Based Settings In The United States: Trends From 2002 To 2012Rhee, T. G. / Schommer, J. C. / Capistrant, B. D. / Hadsall, R. S. / Uden, D. L. et al. | 2016
- A4
-
Market Access And Pricing Disparities of Anticancer Drugs Marketed In The Oecd Countries: Which Reality?Aissaoui, A. / Bin Sawad, A. et al. | 2016
- A4
-
Dealing With Uncertainty And Accounting For Social Value Judgments In Value Assessments For Orphan Drugs: Qualitative Evidence From Four European CountriesNicod, E. / Berg Brigham, K. / Durand-Zaleski, I. / Kanavos, P. et al. | 2016
- A4
-
Prices of Drugs For Chronic Use With Orphan Designation In The UNITED STATES (1983–2014)Alhawwashi, S. / Seoane-Vazquez, E. / Eguale, T. / Rodriguez-Monguio, R. et al. | 2016
- A4
-
Generic Injectable Shortages AND TRENDS IN Average Sales Price In The United StatesHur, P. / Ray, D. / Vegesna, A. / Obi, E. N. et al. | 2016
- A4
-
Natural Language Processing-Identified Problem Opioid Use And Its Associated Health Care CostsMasters, E. T. / Mardekian, J. / Ramaprasan, A. / Saunders, K. / Gross, D. E. / Palmer, R. E. / Cronkite, D. / Von Korff, M. / Carrell, D. et al. | 2016
- A4
-
Analysis Of Indication Expansions For Orphan-Designated, FDA-Approved Drugs Launched In The United States Between 2005 And 2015Li, J. / Lai, R. / Asabere, A. / Bastian, A. et al. | 2016
- A5
-
Economic Evaluation of An Automated Retinal Image Analysis In Australian Aboriginal And Torres Strait Islander Populations For Detection of Diabetic RetinopathyBallreich, J. / Burnett, A. / Frick, K. / Ho, A. / Arkapaw, L. / Kleinert, A. et al. | 2016
- A5
-
Exploring Issues In Analyzing National Databases Using Logistic Regression: Application Of Medical Expenditure Panel SurveyAlthemery, A. U. / Lai, L. / Alfaifi, A. et al. | 2016
- A5
-
Economic Evaluation of A Mental Health Engagement NetworkIsaranuwatchai, W. / Warner, L. / Ethridge, P. / Hoch, J. S. / Forchuk, C. et al. | 2016
- A5
-
Economic Analysis of Drug-Coated Balloons And Other Endovascular Treatments For Femoropopliteal Artery Disease In The United KingdomPietzsch, J. B. / Geisler, B. P. / Garner, A. M. / Zayed, H. / Cleveland, T. / Katsanos, K. et al. | 2016
- A5
-
Cost Effectiveness of Adding Clostridial Collagenase Ointment To Standard of Care In Individuals With Stage IV Pressure UlcersCarter, M. / Gilligan, A. / Waycaster, C. R. / Schaum, K. et al. | 2016
- A6
-
The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In MedicareRoth, J. / Sullivan, S. D. / Ramsey, S. / Goulart, B. et al. | 2016
- A6
-
Bariatric Surgery In Adolescents: A Cost-Effectiveness AnalysisKlebanoff, M. J. / Chhatwal, J. / Nudel, J. D. / Corey, K. E. / Kaplan, L. M. / Hur, C. et al. | 2016
- A6
-
A Cost-Effectiveness Analysis of A Test That Predicts Risk of Malignant Progression In Barrett’s EsophagusHao, J. / Snyder, S. R. / Pitcavage, J. M. / Critchley-Thorne, R. et al. | 2016
- A6
-
Use of Joinpoint Regression To Define Phases of Care In Patients With Advanced Melanoma: An Evaluation From Metastatic Diagnosis Until DeathNunna, S. / Coutinho, A. D. / Eaddy, M. / Landsman-Blumberg, P. et al. | 2016
- A6
-
2015 Update Of Health Technology Assessment Decisions Across The Globe: A Focus On OncologyClark, R. S. / Campbell, C. M. / Meyer, K. L. / Bramley, T. J. et al. | 2016
- A7
-
Early Impact Of Medicaid Expansion On Prescription Drug Utilization And SpendingMahendraratnam, N. / Dusetzina, S. / Farley, J. et al. | 2016
- A7
-
Comparison of Insulin And Non-Insulin Treatment Modification Within 90 Days of An Hba1c Greater Than or Equal To 9% On Diabetes Progression Rates In A Medicare Advantage Cohort Over 4 YearsAbbass, I. M. / Collins, J. C. / Harvey, R. A. / Suehs, B. / Uribe, C. / Kimball, E. / Bouchard, J. / Renda, A. M. / DeLuzio, T. / Allen, E. et al. | 2016
- A7
-
Cost-Effectiveness of Dulaglutide, Liraglutide, And Glargine In Adult Patients With Diabetes Mellitus In ColombiaLasalvia, P. / Baquero, L. / Restrepo, P. / Otálora, M. / Castañeda-Cardona, C. / Rosselli, D. et al. | 2016
- A7
-
Real-World Treatment Patterns In Patients With Type 2 Diabetes Mellitus Newly Initiated With Antihyperglycemic Medications In The United StatesCai, J. / Burudpakdee, C. / Divino, V. et al. | 2016
- A7
-
Patient-Centered Medical Home And Annual Health Care Expenditures Among Children With Special Health Care Needs: New Evidence From Medical Expenditure Panel SurveyLin, C. / Romley, J. / Carlin, C. et al. | 2016
- A7
-
Estimating The Societal Costs Associated With Glp-1ras In The United States For The Treatment of Type 2 DiabetesWang, B. C. / Nguyen, H. / Furnback, W. / Guzauskas, G. F. / Hurd, J. / Garrison, L. P. et al. | 2016
- A8
-
Multi-Indication Pricing: Pros, Cons, And Its Applicability To The United KingdomMestre-Ferrandiz, J. / Towse, A. / Dellamano, R. / Pistollato, M. et al. | 2016
- A8
-
Health Care Expenditures Associated With Persistent Emergency Department Use: A Multi-State Analysis of Medicaid BeneficiariesAgarwal, P. / Bias, T. / Sambamoorthi, U. et al. | 2016
- A8
-
Predictors of Intentional and Unintentional Non-Adherence and Associated Health Utilities among Women Receiving Oral Treatments for Breast CancerGoren, A. / Gupta, S. / Lee, L. / Wen, K. / Geynisman, D. et al. | 2016
- A8
-
Medication Adherence among Hiv/Aids Patients Receiving 340b-Purchased Antiretroviral MedicationsClark, B. / Hou, J. / Huang, E. / Conti, R. / Chou, C. et al. | 2016
- A8
-
A Comparison Of Indications And Hta Decisions For Hepatitis CShayna Rosenblum, B. / Lurie, B. / Rubinstein, J. / Adler, B. / Veroza, L. / Sliman, R. et al. | 2016
- A9
-
Impact of Medication Adherence on Hospitalization in MedicaidRoebuck, M. / Dougherty, J. et al. | 2016
- A9
-
Does A Web-Based Decision Aid Help Parents in making a Decision to Vaccinate their Child against Hpv: Findings from AlbertaTiwana, S. / Johnston, C. / Webb, J. et al. | 2016
- A9
-
Qaly Gains in Cancer Compared with Chronic DiseasesSandberg, E. / Thorat, T. / Neumann, P. / Chambers, J. et al. | 2016
- A9
-
Validity of Health Preferences Elicited from Children: Comparing Choice Blindness and Stated Preferences between Children and AdultsLaw, E. / Pickard, A. / Kaczynski, A. et al. | 2016
- A9
-
Association between Work Time Loss and Quality of Life in Patients with Herpes Zoster: A Pooled Analysis of the Master StudiesAcosta, C. / Rampakakis, E. / Tsai, T. / Cheong, H. / Dhitavat, J. / Ortiz-Covarrubias, A. / Stutz, M. / Cashat-Cruz, M. / Monsanto, H. / Johnson, K. et al. | 2016
- A10
-
The Role Of Sleep Quality Improvement Training Within Workplace Health PromotionSzabó, J. / Markó, Z. / Csákvári, T. / Gombos, G. / Steinhausz, V. / Sió, E. / Turcsányi, K. / Boncz, I. / Pakai, A. et al. | 2016
- A10
-
Post-Operative Pain Management Association With Health Economic OutcomesRobinson, S. et al. | 2016
- A10
-
The Risk Of Chronic Pancreatitis In Patients With Psoriasis: A Population-Based Matched Cohort StudyHsieh, C. / Chiu, H. / Chiang, Y. / Tsai, T. / Tsai, Y. / Huang, W. et al. | 2016
- A10
-
Retrospective Study To Compare Medication Utilization Between Physician-Managed And Pharmacist-Managed Groups In State Correctional Facilities Among An Hiv PopulationVu, H. / Shaya, F. / Barnes, V. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A10
-
Role Of Glycemic Control In Development Of Atrial Fibrillation In Patients With Type 2 Diabetes MellitusSinghal, M. / McAdam-Marx, C. / LaFleur, J. / Witt, D. / Nelson, R. / Biskupiak, J. et al. | 2016
- A10
-
Assessment Of Who/Inrud Patient-Care And Facility-Specific Indicators In The Ophthalmology Wards Of Two Tertiary Care Hospitals In PakistanAtif, M. / Rehan Sarwar, M. / Azeem, M. / Qamar-Uz-Zaman, M. / Arslan, B. / Nauman, A. / Zeshan, M. et al. | 2016
- A11
-
The Burden Of Atopic Dermatitis In Adults: Results From The 2013 United States National Health And Wellness Survey (Nhws)Whiteley, J. / Emir, B. / Seitzman, R. / Makinson, G. et al. | 2016
- A11
-
Use Of Real-World Data To Estimate Cardiovascular Event Rates Among Elderly High Cardiovascular Risk Patients With Medicare Supplemental Insurance In The United StatesQuek, R. / Hardin, J. / Bonafede, M. / Johnson, B. / Gandra, S. et al. | 2016
- A11
-
Knowledge, Awareness, And Prevalence Among Community Regarding Hepatitis B And C In Abbottabad, Kpk, PakistanAzhar, S. / Syed, A. / Yousaf, A. / Khan, T. / Mansoor, Z. / Haq, N. et al. | 2016
- A11
-
Use Of Real-World Data To Estimate Cardiovascular Event Rates Among Non-Elderly Commercially Insured High Cardiovascular Risk Patients In The United StatesQuek, R. / Hardin, J. / Bonafede, M. / Johnson, B. / Gandra, S. et al. | 2016
- A11
-
Bidirectional Screening Of Comorbid Tuberculosis And Diabetes And Its Effect On Tuberculosis Treatment OutcomesAzhar, S. / Umer, R. / Shahid, M. et al. | 2016
- A12
-
Potential Drug-Drug Interactions In Renal Impairment Patients In PakistanSaleem, A. / Masood, I. / Khan, T. M. / Nawaz, M. et al. | 2016
- A12
-
Aspects Of Family Life In Young People In A Region Of Colombia In 2014Alvis Zakzuk, J. / Salcedo Mejía, F. / Alvis Guzman, N. / Paz Wilches, J. / Manrique Mclean, J. et al. | 2016
- A12
-
Death Burden Of Pneumococcal Disease On Brazilian Private Health SystemSantos, M. / Ferreira, C. / Squiassi, H. / Santana, C. et al. | 2016
- A12
-
A Budget Impact Analysis Establishing The Economic Benefit Of The Sandostatin® Lar® Mobile Administration Program In CanadaPanchmatia, H. / Becker, D. / Choe, Y. / Gu, Q. et al. | 2016
- A12
-
Emergency Department Visits Associated With Ankle Sprains In The United StatesShah, S. / Thomas, A. / Noone, J. / Blanchette, C. / Wikstrom, E. et al. | 2016
- A12
-
Determination Of Medication Errors And Economic Implications To One Year Of The Establishment Of Clinical Pharmacy Service In Medical Oncology Unit: Experience In A Hospital Of Cancer In MexicoHernández Martínez, J. / Morales Perez, M. / Toledo Vigueras, I. / Colín Gómez, D. / Paredes García, P. / Sánchez Rodríguez, I. et al. | 2016
- A13
-
A Retrospective Study To Compare The Medication Costs Of An Hiv Population In State Correctional Facilities Between The Physician-Managed And Pharmacist-Managed GroupsVu, H. / Shaya, F. / Barnes, V. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A13
-
Cost And Clinical Outcomes Of A Pharmacist-Led Intervention Program To Reduce Utilization High-Risk Sedative Hypnotics And Skeletal Muscle Relaxants In The Elderly Population With DepressionYu, S. et al. | 2016
- A13
-
A Retrospective Study To Compare Medication Costs Of A Hepatitis C Population In State Correctional Facilities Between Physician-Managed And Pharmacist-Managed Treatment GroupsVu, H. / Shaya, F. / Barnes, V. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A13
-
Impact Of The Aca: Medication Therapy Management Services For American Indian Patients On Reservations With Cardiovascular Disease And Self-Insurance PlansSt. Germaine, R. et al. | 2016
- A13
-
Total Knee Arthroplasty Post Acute Care Costs By Discharge StatusZeng, F. / Waldo, D. et al. | 2016
- A13
-
Total Cost Of Care In Real-World Patients With Advanced Non-Small Cell Lung Cancer Treated With Antineoplastic TherapyRadtchenko, J. / Korytowsky, B. / Bhor, M. / Tuell, K. / Feinberg, B. et al. | 2016
- A14
-
Estimating Health Benefits And Lifetime Economic Cost-Savings From Promoting Breastfeeding To Prevent Childhood Leukemia In The United StatesEkwueme, D. / Hung, M. / Guy, G. / Rim, S. et al. | 2016
- A14
-
Economic Surveillance For Chronic Obstructive Pulmonary Disease In Alberta, CanadaWaye, A. / Jacobs, P. / Ospina, M. / Stickland, M. / Mayers, I. et al. | 2016
- A14
-
Excess Direct Medical Expenditures Associated With Dementia Among Elderly (>=65 Years) IndividualsDeb, A. / Sambamoorthi, U. / Schreurs, B. / Innes, K. et al. | 2016
- A14
-
Economic Evaluation Of 2014 Cholera Outbreak In Ghana: A Household Cost Analysis In High And Low Incidence SettingsAwalime, D. / Davies-Teye, B. / Vanotoo, L. / Owoo, N. / Nketia-Amponsah, E. et al. | 2016
- A14
-
Economic Burden Of Moderate Chronic Kidney Disease In Type 2 DiabetesMcQueen, R. / Farahbakhshian, S. / Bell, K. / Nair, K. / Saseen, J. et al. | 2016
- A14
-
Health Care Expenditures, Prescription Drug Cost, And Out-Of-Pocket Spending Among Adults With Chronic Disease Condition Combinations In The United StatesSakharkar, P. et al. | 2016
- A15
-
Economic Evaluation Of 2014 Cholera Outbreak In Ghana: A Patient Level And Health Care System Cost Analysis In An Urban SettingsDavies-Teye, B. / Awalime, D. / Davies-Teye, S. / Vanotoo, L. et al. | 2016
- A15
-
Economic Burden Of Hematopoietic Cell Transplant Among Patients With Hematologic MalignanciesBonafede, M. / Cai, Q. / McMorrow, D. / Garfin, P. / Teasell, J. / Richhariya, A. et al. | 2016
- A15
-
Clinical And Economic Burden Of Bloodstream Infections Following Central Venous Catheter Placement In The Intensive Care UnitBrunelli, S. / Turenne, W. / Sibbel, S. / Hunt, A. / Pfaffle, A. et al. | 2016
- A15
-
Costs Of Cancer From The Patient/Caregiver PerspectiveAlbarmawi, H. / Onukwugha, E. et al. | 2016
- A15
-
The Service Utilization And Cost Of Hiv Treatment In Mbagathi District Hospital, KenyaOwiti, E. et al. | 2016
- A16
-
Out-Of-Pocket Health Expenditures In Patients With Uncontrolled Asthma From ColombiaZakzuk, J. / Parra, D. / Salcedo Mejía, F. / Alvis-Zakzuk, J. / Buendia, E. / Caraballo, L. / Alvis-Guzmán, N. et al. | 2016
- A16
-
Outcomes, Health Care Resources Use, And Costs In Patients With Post-Myocardial Infarction: The Horus Cohort Study In The Egb French Claims And Hospital DatabaseBlin, P. / Dureau-Pournin, C. / Lassalle, R. / Jové, J. / Thomas-Delecourt, F. / Droz-Perroteau, C. / Danchin, N. / Moore, N. et al. | 2016
- A16
-
Costs Of End-Of-Life Treatments Among Elderly Metastatic Colon Cancer PatientsSieluk, J. / Hanna, N. / Goto, D. / Seal, B. / Mullins, C. et al. | 2016
- A16
-
Severe Hypoglycemias Treatment Costs (Inpatient) At Institutional Level In MexicoCamacho-Cordero, L. / Baez-Revueltas, F. / Herran, S. / Huicochea-Bartelt, J. / Yamamoto, J. et al. | 2016
- A16
-
Cost Assessment Of Sojourn Catheter Use In Chronic Renal PatientsVianna, C. / Souza, R. / Silva, F. / Mosegui, G. / Peregrino, A. et al. | 2016
- A16
-
Opportunity Cost And Health Impact Of Prenatal Care In Pregnant Women With Public Health Insurance In ColombiaGomez de la rosa, F. / Marrugo Arnedo, C. / Florez tanuz, A. / Lopez pajaro, K. / Mazenett granados, E. / Orozco Africano, J. / Alvis Guzman, N. et al. | 2016
- A17
-
Characteristics And Health Care Utilization Among Adults With Chronic Obstructive Pulmonary Disease According To Missed Work Status: A Retrospective Analysis Of The Medical Expenditure Panel SurveyDashputre, A. / Kamal, K. / Covvey, J. et al. | 2016
- A17
-
Cost-Effectiveness Analysis Of Neonatal Screening Of Critical Congenital Heart Defects In ChinaGai, R. et al. | 2016
- A17
-
Income Growth Trajectory For Parents Of Children With Down Syndrome In The United StatesSamuelson, D. / Kageleiry, A. / Duh, M. / Lefebvre, P. / Campbell, J. / DerSarkissian, M. / Haider, B. / Skotko, B. et al. | 2016
- A17
-
Cost Of Inflammatory Bowel Disease Hospitalizations In IrelandBaj, R. / Hogan, A. et al. | 2016
- A17
-
Cost-Effectiveness Analysis Of Pharmaceutical Care For Type 2 Diabetes Mellitus Pacients In Ribeirão Preto BrazilPicoli, R. / Pereira, L. / Barros, M. / Nunes, A. / Costa, A. et al. | 2016
- A17
-
Cost Effectiveness Of A Diabetes Self-Management Education Programme Of Type 2 Diabetes Patients In Riyadh, Saudi ArabiaAlaboudi, I. et al. | 2016
- A18
-
Development and Validation of Patient Decision Aid for Antidepressant MedicationsAl Jumah, K. et al. | 2016
- A18
-
Economic Evaluation Of The Functioning Of Cytotoxic Drug Reconstitution UnitDiarra, Z. / Cherrah, Y. / Meddah, B. / Ahid, S. et al. | 2016
- A18
-
Value-Based Health CareOkoro, K. / Urama, C. et al. | 2016
- A18
-
Assessment of Patient Adherence and Utilization of Sofosbuvir-Based Regimens: A Real-World Data AnalysisParekh, M. / Kamal, K. / Miller, R. / Koerner, P. / Giannetti, V. / Craft, Z. et al. | 2016
- A18
-
Assessment of Pharmacist-Mediated Education on Medication Adherence Behaviour in Type 2 Diabetes Mellitus PatientsAdepu, S. / Ramanath, K. / Bhat, S. / SAM, S. / Omanakuttan, C. et al. | 2016
- A18
-
Patient-Related Barriers to Medication Adherence In Type 2 Diabetic Patients: A Systematic ReviewSalkar, M. / Sah, J. / Pinto, S. / Vaidya, V. et al. | 2016
- A19
-
Knowledge, Attitudes, And Practice Towards Use of Long-Term Family Planning Methods Among Women Aged 15-49 Years: A Community-Based Survey in an Urban Ugandan SettingKiyingi, R. / Tuhebwe, D. / Nalwanga, E. / Ssegujja, E. / Anguzu, R. / Nakku-Joloba, E. et al. | 2016
- A19
-
Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting: Physician PerspectiveKhairnar, R. / Kamal, K. / McConaha, J. / Giannetti, V. / Dwibedi, N. et al. | 2016
- A19
-
Colorectal Cancer Patient Satisfaction with the Multidisciplinary Treatment in a High Specialty Unit at Instituto Mexicano Del Seguro SocialSat-Muñoz, D. / Balderas-Peña, L. / Palomares-Chacon, U. / Salas-Barragán, C. / Martinez-Herrera, B. et al. | 2016
- A19
-
Impact of Pharmacist Intervention Using Shared Decision Making on Adherence and Measurable Depressed Patient OutcomesAljumah, K. et al. | 2016
- A19
-
The Impact of a Decision Aid on Depressed Patients’ Involvement in Shared Decision Making: A Pilot Randomized Controlled Double-Blinded StudyAl Jumah, K. et al. | 2016
- A20
-
Predictors of Unhealthy Days in Patients with Metastatic Breast, Lung, Or Colorectal CancerCasebeer, A. / Drzayich Antol, D. / Hopson, S. / Khoury, R. / Parikh, A. / Stein, A. / Michael, T. / Stemkowski, S. / Bunce, M. et al. | 2016
- A20
-
Awareness and Impact of International Normalized Ratio Monitoring in Ongoing Anticoagulation Therapy in Cardiac PatientsPal, M. / Bandari, S. / Sekar, M. / Gier, S. et al. | 2016
- A20
-
Race, Sex, And Geographic Variations in Depression among Cancer Patients in the United StatesAdjei Boakye, E. / Mohammed, K. / Osazuwa-Peters, N. / Buchanan, P. / Chen, J. / Burroughs, T. et al. | 2016
- A20
-
Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting: Patient PerspectiveKhairnar, R. / Kamal, K. / McConaha, J. / Giannetti, V. / Dwibedi, N. et al. | 2016
- A20
-
Validation of The Dhds: A Hybrid Instrument to Measure Health-Related Quality-Of-Life in Patients with Diabetes, Hypertension, and DyslipidemiaBae, Y. / Pham, D. / Bounthavong, M. / Law, A. et al. | 2016
- A20
-
Depression Treatment and Health-Related Quality of Life Among Adults with Arthritis and Depression in the United StatesShah, D. / Dwibedi, N. / Sambamoorthi, U. et al. | 2016
- A21
-
Assessing Patient-Perceived Barriers to Routine Counseling Services offered by Community PharmacistsBrinkerhoff, A. / Pinto, S. et al. | 2016
- A21
-
The Impact of Different Approaches to Addressing Missing Items in Cancer Experience SurveysRoydhouse, J. / Gutman, R. / Keating, N. / Mor, V. / Wilson, I. et al. | 2016
- A21
-
Systematic Review of International Models of Care on Rare DiseasesChirveches, M. / Aroca, A. / Otálora, M. / Quirland-Lazo, C. / Pacheco, B. / Polanía, M. / Zamora, M. / Barrera, L. / Holguín, A. / Castañeda-Cardona, C. et al. | 2016
- A21
-
Consequences of Medicare Part D Plan Switching: Gain or LossHan, J. / Ko, D. et al. | 2016
- A21
-
Utilization of Cervical Cancer Preventive Care Services: Does Marital Status Matter?Gunjal, S. / Mgbere, O. / Wang, X. / Essien, E. et al. | 2016
- A22
-
Profiles of Performance of Health Service Providers to Implement a Pay-For-Performance Mechanism: Simulation ApproachPinzón-Flórez, C. / Pérez-Gómez, A. / Castillo-Londoño, J. et al. | 2016
- A22
-
Awareness Gap of Cataract and Age-Related Macular Degeneration among Korean Elderly PatientsLee, H. / Kang, H. et al. | 2016
- A22
-
Association between Self-Monitoring Behavior and Self-Management Education among Americans with DiabetesAdjei Boakye, E. / Rojek, R. / Varble, A. / Peavler, O. / Trainer, A. / Hinyard, L. et al. | 2016
- A22
-
The Cost of Serious Adverse Events in Multi-Drug-Resistant Tuberculosis Treatment: Experience from EthiopiaGama, E. / Girma, M. et al. | 2016
- A22
-
Barriers and Facilitators to Anticoagulation Patient Self-Testing: National Survey of Anticoagulation Providers in the United StatesManzoor, N. / Goncharenko, A. / Nutescu, E. et al. | 2016
- A22
-
Evaluation of an Integrated Care Pathway for Rectal Cancer Treatment Implementation Using a Logic ModelKobayashi, S. / Campolina, A. / Soarez, P. / Ribeiro, J. U. / Diz, M. / Hoff, P. et al. | 2016
- A23
-
Unlocking Smartphone Potential in Health Care by Providing Smartphones to Patients: A Systematic ReviewNamil, M. / White, A. / Weltman, N. / Carter, P. / Trinh, J. / Dsouza, K. / Loving, C. / Dang, C. / Jacob, S. et al. | 2016
- A23
-
Multifaceted Interventions Reduce 30-Day Hospital Readmissions in At-Risk Medicaid Members from Four States and The District of ColumbiaGao, W. / Keleti, D. / Donia, T. / Jones, J. / Michael, K. / Gelzer, A. et al. | 2016
- A23
-
Monitoring of Health Care Utilization 3 Months Prior to A Chronic Obstructive Pulmonary DiseaseHur, P. / Stuart, B. / Tom, S. et al. | 2016
- A23
-
Development and Validation of Psychological Intervention Guideline for Patients Diagnosed with Non-Communicable Chronic DiseasesDíaz-Sotelo, O. / Orozco, A. / Cabrera-Infante, K. / Pinzón, L. et al. | 2016
- A23
-
Evidence-based recommendations for psychological intervention to patients diagnosed with rheumatoid arthritisOrozco, A. / Díaz-Sotelo, O. / Lara-Meléndez, P. / Quintero-Aguirre, L. et al. | 2016
- A24
-
Analysis on the Utilization Status of Essential Medicines in Beijing’s Community Health InstitutionsZhang, F. / Li, S. / Yang, Y. et al. | 2016
- A24
-
Overview of Oncology Centers Structures in both Public and Private Brasilian Health Care SystemNita, M. / Mussolino, F. / Vaz, P. / Riveros, B. / Tolentino, A. et al. | 2016
- A24
-
Association Between Affordable Care Act-Covered Preventive Care Use and Emergency Room Visits and Costs in AdultsWang, Y. / Cobran, E. et al. | 2016
- A24
-
The Study of Understanding of Health Professionals’ Liability Insurance among Medical Doctors in MongoliaSambuu, T. / Byambaa, G. / Luvsan, M. et al. | 2016
- A24
-
Over- And Underuse of Therapeutic and Palliative Care Services for Cancer Patients at End of Life: A Population-Based StudyRamsey, S. / Goulart, B. / Conklin, T. / McGee, R. / Lyman, G. / Mera, C. / Smith, B. et al. | 2016
- A24
-
The Relationship between Preventive Care Visits and School Absences among Children with AsthmaRojanasarot, S. / Carlson, A. et al. | 2016
- A25
-
A Cross-Sectional Survey of Community Pharmacists towards Antimicrobial Stewardship in MalaysiaKhan, M. / Ahmad, A. / Elkalmi, R. / Zaidi, S. et al. | 2016
- A25
-
Economic Evaluation of School-Based Health Centers: A Community Guide Systematic ReviewRan, T. / Chattopadhyay, S. / Hahn, R. et al. | 2016
- A25
-
Assessment of Association between Health Insurance Coverage and Diabetes Care Quality Using Difference-In-Differences AnalysisZhang, S. / Thomas III, J. et al. | 2016
- A25
-
Racial and Ethnic Differences in the Use of Preventive Services among Cancer Survivors in the Medicare ProgramCheng, X. / Lee, M. / Salloum, R. et al. | 2016
- A25
-
Impact of Out-Of-Pocket Costs on Medication Adherence among Patients with Type 2 DiabetesBibeau, W. / Nelson, D. et al. | 2016
- A26
-
Government Reimbursement Values versus Real Chemotherapy Costs in the Brazilian Public Health Care System: Another Barrier to Treatment Access?Lemmer, T. / Goes, L. / Piedade, A. et al. | 2016
- A26
-
Differential Access to Care between Depressed and Non-Depressed Children in a Patient-Centered Medical HomePapademetriou, E. / Sam, Z. / Dutta, S. et al. | 2016
- A26
-
Emergency Department Optimization: Improving Timeliness of Patient CareDas, D. / Sir, M. / Nestler, D. / Hellmich, T. / Marisamy, G. / Pasupathy, K. et al. | 2016
- A26
-
Generation and Evaluation of an Indicator of Health System Performance for Maternal and Reproductive Health in Colombia: An Ecological StudyPinzón Flórez, C. / Fernández-Niño, J. / Cardenas-Cardenas, L. / Ruiz-Rodriguez, M. / Reveiz, L. et al. | 2016
- A26
-
Timeliness of Care among Elderly Women with Breast Cancer: A Population-Based Observational StudyVyas, A. / Madhavan, S. / Sambamoorthi, U. et al. | 2016
- A26
-
Effects of the Quality Blue Primary Care Program on Health Outcomes in Patients Covered by the Blue Cross Blue Shield of LouisianaShi, Q. / Shi, L. / Lee, P. / Murphree, P. / Yuan, X. et al. | 2016
- A27
-
Final Year Pharmacy Students’ Perception towards Generic Medicines: A Questionnaire-Based Study from YemenAL-Tamimi, S. / Shafie, A. et al. | 2016
- A27
-
Improving Access for Surgical Patients using Various PoliciesMartinez, G. / Sir, M. / Pasupathy, K. et al. | 2016
- A27
-
Factors Associated with 30-Day Readmission after Hip/Pelvic Fracture Inpatient StaysLin, I. / Menzin, J. et al. | 2016
- A27
-
The Impact of High-Deductible Health Plans on the Financial Burden of Commercially Insured Population in The United StatesZhang, X. / Sood, N. et al. | 2016
- A27
-
Impact of Inclusion of Problem-Based Learning with Conventional Teaching Method to Develop Skills in Pharmacy Undergraduates: Does it Really Helpful to Enhance their Skills?Kashyap, M. / Bahari, B. et al. | 2016
- A27
-
Characterizing Emergency Department Utilization among Pediatric Patients with Tympanostomy TubesTam, I. / Candrilli, S. / Moss, J. et al. | 2016
- A28
-
Impact of an Ambulatory Care Pharmacy-Based Transition of Care Program on Hospital Readmissions and CostNi, W. / Colayco, D. / Hashimoto, J. / Komoto, K. / Gowda, C. / Wearda, B. / McCombs, J. et al. | 2016
- A28
-
National Trends in Direct Health Care Expenditures among Adults with Migraine in the United States: 2004-2013Shah, A. / Raval, A. et al. | 2016
- A28
-
Impact of Depression on Health Expenses and Medical Utilization in Adults with MigraineWu, J. / Davis-Ajami, M. / Lu, K. et al. | 2016
- A28
-
Clinical and Economic Burden of Mental Disorders in Children with Chronic Physical Conditions in the United StatesSuryavanshi, M. / Yang, Y. et al. | 2016
- A28
-
Arthritis-Related Medical Care Utilization and Expenditures Under Gatekeeper and Non-Gatekeeper Plans Using Medical Expenditure Panel Survey (Meps) DataMa, X. / Park, C. / Lawson, K. et al. | 2016
- A29
-
The Economic Cost of a Death Event in the Brazilian Private Health Care SystemSantos, M. / Ferreira, C. / Squiassi, H. / Santana, C. et al. | 2016
- A29
-
Economic Burden Attributable to Obesity in Adult Patients with Rheumatoid Arthritis in the United StatesKang, H. / Makhinova, T. / Ogunsanya, M. / Ma, X. / Lawson, K. et al. | 2016
- A29
-
The Economic Burden of Types of Comorbidity for Patients with Diabetes MellitusAn, J. / Le, Q. et al. | 2016
- A29
-
Health Care Utilization and Costs Associated with Potential Refractory Epilepsy in Texas MedicaidGupte-Singh, K. / Barner, J. / Wilson, J. / Hovinga, C. / Richards, K. / Rascati, K. et al. | 2016
- A29
-
Compounding Pharmacies: Workers’ Compensation CostIyengar, R. / Henderson, R. / Nelson, B. et al. | 2016
- A29
-
Costs of Diabetes-Related Hospitalization and Peripheral Lower-Extremity Disease-Related Hospitalization in the United StatesZhao, R. / Carlson, A. et al. | 2016
- A30
-
Evaluation of Asthma Outcomes in Older and Younger AdultsHines, D. / Sery, P. / Blanchette, C. et al. | 2016
- A30
-
National Trends in Direct Health Care Costs Associated with Endometriosis among Females in the United States: 2004-2013Shah, A. / Raval, A. / Thakker, D. et al. | 2016
- A30
-
Factors Associated with Health Care Utilization by Members of Qualified Health Plans: Emergency Room Versus Primary Care Provider VisitsPulungan, Z. / Teigland, C. / Parente, A. / Kilgore, K. / McClellan, M. et al. | 2016
- A30
-
Provider and Payer-Related Indicators of Commercial Price Variation in Professional Services in VermontErten, M. / London, K. / Grenier, M. / Jones, C. et al. | 2016
- A30
-
Demographic Characteristics of High Medication Spenders in a State Correctional SystemVu, H. / Shaya, F. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A31
-
Estimating the Arthroplasties Revision Rates and Lifetime of Knee and Hip Prosthesis in the State of São Paulo, BrazilOliveira, F. / Barbosa, E. / Junqueira Junior, S. / Oliveira, D. / Luque, A. / Cabra, H. et al. | 2016
- A31
-
Cost Comparison between the Manual System and Automated Dispensing Systems; How to Use Effective Health Technology at a Large Academic Hospital in ThailandNoparatayaporn, P. / Thaweethamcharoen, T. / Sakulbumrungsil, R. / Sangseenil, W. et al. | 2016
- A31
-
Characteristics of a High Medication Cost Group in State Correctional FacilitiesVu, H. / Shaya, F. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A31
-
A Descriptive Study of Medication Expenditures and Consumption in State Correctional FacilitiesVu, H. / Shaya, F. / Seo, H. / Rodriguez de Bittner, M. et al. | 2016
- A31
-
Lower Costs and Resource Use in Patients Who Use Onsite Health ClinicsLalla, D. / Hilu, K. / Niecko, T. / Kaszpurenko, J. / Shreeve, S. et al. | 2016
- A31
-
Health Technology Assessment on an Automated Blood Transport System for Inpatient Wards: First Step in Supporting the Decision-Making Process in University Hospitals of ThailandThaweethamcharoen, T. / Noparatayaporn, P. / Nopmaneejumruslers, C. / Luenee, P. et al. | 2016
- A32
-
Impact of patient nonadherence to diabetes treatment on complication risks and health care costsMizobe, M. / Fukuda, H. et al. | 2016
- A32
-
Assessment and Characterization of Gaps in Literature of Resource Utilization and Economic Burden in Inflammatory MyopathiesGala, S. / Mwamburi, M. et al. | 2016
- A32
-
Determining the Value of a Health System/School Partnership to Provide School Health and Pediatric Care in School: A Cost-Benefit AnalysisMueller, J. / Johnson, S. / Connor, K. / Calderon Velazquez, G. / Padula, W. et al. | 2016
- A32
-
The Concentration of Health Care Expenditure of a Colombian Public Health Insurance CompanyMarrugo Arnedo, C. / Florez tanuz, A. / Gomez de la rosa, F. / Lopez pajaro, K. / Orozco Africano, J. / Alvis Guzman, N. et al. | 2016
- A32
-
Final Year Medical Students’ Perception Towards Generic Medicines in Southeast YemenAL-Tamimi, S. / Hassali, M. / Shafie, A. / Alrasheedy, A. et al. | 2016
- A32
-
Effect of Financial Incentives on Health Promotion ParticipationNavratil-Strawn, J. et al. | 2016
- A33
-
A Description of the Adult Population’s Medication Experiences in the United States Using an Agglomerative Hierarchical Clustering MethodOlson, A. / Schommer, J. / Tieger, P. / Brown, L. et al. | 2016
- A33
-
Prevalence and Risk Factors of Alcohol Consumption in Young Poor People with Public Health Insurance from a Region of ColombiaSalcedo Mejía, F. / Alvis Zakzuk, J. / Alvis Guzman, N. et al. | 2016
- A33
-
Reducing Young Invincibles’ Health Care Spending through the Aca Expansion of Dependent CoverageChen, J. / Vargas-Bustamante, A. / Novak, P. et al. | 2016
- A33
-
Costs of Non-Adherence in Hypertensive Patients Affiliates to Health Insurance in CartagenaAlvis Estrada, L. / Alvis Guzman, N. / Paz Wilches, J. et al. | 2016
- A33
-
Association of Patient-Centered Care and Seeking Insurance from Health Exchanges by the Low-Income People: Evidence from the Health Information National Trend SurveyHaider, M. / Qureshi, Z. / Khan, M. et al. | 2016
- A33
-
Knowledge, Attitude, and Perception of Future Pharmacists Regarding Pharmacovigilance in PakistanSyed, A. / Azhar, S. / Jamshed, S. / Dawood, M. / Asghar, M. et al. | 2016
- A34
-
Medication Therapy Management Interventions in Emergency and Ambulatory Care in Northwest EthiopiaBhagavathula, A. / Melaku, T. / Getaye, Y. / Getachew, H. et al. | 2016
- A34
-
Monitoring System of Patients with Chronic Neurological DisordersBlavatska, O. / Grynkiv, I. / Blavatskyj, I. et al. | 2016
- A34
-
Pharmacy-Led Medication Reconciliation Programs at Hospital Transitions: A Systematic Review and Meta-AnalysisMekonnen, A. / McLachlan, A. / Brien, J. et al. | 2016
- A34
-
Independent Factors Affecting Patient Compliance to Private Insurer-Funded Health Case Management in CanadaChen, W. / Krupitsky, Y. / Currie, B. / Lunny, R. / Baumgartner, A. / Molloy-Whaley, E. / Anderson, S. et al. | 2016
- A34
-
Association between Neighborhood Socioeconomic Status, Stroke Center Admission, and Mortality after Ischemic and Ill-Define StrokeOhinmaa, A. / Zheng, Y. / Jeerakathil, T. / Klarenbach, S. / Hakkinen, U. / Nguyen, T. / Chuck, A. / Friesen, D. / Ruseski, J. / Kaul, P. et al. | 2016
- A35
-
A Transitions of Care Collaboration between Pharmacy Academia and a Community Health SystemBradford, C. / Thanh, D. / Kwong, M. / Chang, L. / Shah, B. / Sui, L. / Young, G. et al. | 2016
- A35
-
Factors Influencing Access to Medicines in Nigeria: Views and Experiences of Residents of the Federal Capital TerritoryUmoru, A. / Alfa, J. / Adigwe, O. et al. | 2016
- A35
-
Drug Therapy of Epileptic Seizures in Adult Epileptic Outpatients of University of Gondar Teaching Hospital, Gondar, North West EthiopiaBirru, E. et al. | 2016
- A35
-
Incentives to Honor Maternal Health Referrals in a Setting with Inequitable Access to Health Care in the Amansie West District in Ashanti RegionNuamah, G. / Agyei-Baffour, P. / Akohene, K. / Boateng, D. / Dobin, D. / Donkor, K. et al. | 2016
- A35
-
Satisfaction of Clients with the Services of an Outpatient Pharmacy at a University Hospital in Northwestern Ethiopia: A Cross-Sectional StudyAS, S. / Teni, F. / Girmay, G. / Tesfa, M. / Moges, E. / Abraha, M. et al. | 2016
- A36
-
Assessment of Drug Utilization Practice in Ophthalmology Department of University of Gondar Referral and Teaching Hospital, North West EthiopiaEshetie Melese Birru, M. et al. | 2016
- A36
-
Development and Implementation of the Medical Audit Process in Health Services at the First Level of Care: A Contextualized Model Adapted to EcuadorTorres Toala, F. et al. | 2016
- A36
-
Erosion of Empathy in Primary Care TraineesMcRae, J. / Calusi, G. / Liu, M. / Scognamiglio, V. / Messina, E. / Polenzani, L. et al. | 2016
- A36
-
Caesarian Section Rate in Hungary between 1960-2013Kovács, G. / Nagy, S. / Endrei, D. et al. | 2016
- A36
-
A Cross-Sectional Assessment of Knowledge, Attitude, and Practice on Hepatitis B and C Patients in Ayub Medical Complex Abbottabad, PakistanAzhar, S. / Syed, A. / Mansoor, Z. / Yousaf, A. et al. | 2016
- A36
-
A Systematic Analysis of the Regulatory Process of Drug Delivery in Social Networks and the Impact on Health Care RussiaStarostina, I. / Krupnova, I. et al. | 2016
- A37
-
Preventive Care Screening Patterns among Women with MedicaidBonafede, M. / Miller, J. / Cai, Q. / Troeger, K. / Pohlman, S. et al. | 2016
- A37
-
Social Impact of a Prenatal Health Care Program at a Health Insurer in ColombiaHO, A. / NE, G. / Muñoz-Galindo, I. / Moreno, J. / Diaz, J. et al. | 2016
- A37
-
Health Technology Assessment: A Trailblazer in Better Patient CarePk, M. et al. | 2016
- A37
-
Developing Beliefs that Support Vaccination: Results from the Pharmacists’ Pneumonia Prevention ProgramMcRae, J. / Prioli, K. / Schafer, J. / Cannon-Dang, E. / Harris, L. / Pizzi, L. et al. | 2016
- A37
-
Health Insurance Coverage and Utilization of Prenatal Care in the United StatesZelle, L. et al. | 2016
- A37
-
A Review of Current Quality Metrics for Evaluating Patient-Centered Medical HomesVarga, S. / Lombardi, M. et al. | 2016
- A38
-
Pneumoconiosis Costs AT the Social Security of PeruMore Yupanqui, G. et al. | 2016
- A38
-
Review of Cardiovascular Quality-Of-Care Metrics across Different Organizations in the United StatesPodlogar, V. / Robinson, J. D. / Saadi, R. et al. | 2016
- A38
-
Impact of Missing Data in Criteria of Least Consensus on Acmg Newborn Screening Recommendations for Short-Chain Acyl-Coa Dehydrogenase DeficiencyYang, K. / Rittenhouse, B. et al. | 2016
- A38
-
Examining Uncertainty around American College of Medical Genetics Recommendations for Newborn Screening for Galactose Epimerase DeficiencyBojan, B. / Rittenhouse, B. et al. | 2016
- A38
-
Overview of National Leading Organizations Involved in Quality of Care in OncologyWen, L. / Divers, C. / Lingohr-Smith, M. / Lin, J. et al. | 2016
- A38
-
Using Clinical Data to Monitor High-Cost, Performance Coding Issues Associated with Pressure Ulcers: A Multilevel AnalysisPadula, W. et al. | 2016
- A39
-
Hmg-Coa Reductase Inhibitors (Statins) associated Tendon Rupture: An Analysis of Reports from the Food and Drug Administration’s Adverse Reporting SystemRafi, J. / Arabyat, R. / Chen, C. / Raisch, D. et al. | 2016
- A39
-
Associations of Comorbidities and Co-Medications with Angioedema during the Use of Angiotensin Converting Enzyme-Inhibitors within the United Kingdom Clinical Practice Research DatalinkMahmoudpour, S. / Baranova, E. / Souverein, P. / Asselbergs, F. / de Boer, A. / Maitland-van der Zee, A. et al. | 2016
- A39
-
Receipt of Guideline-Concordant Surveillance Care in Elderly Patients with Colorectal CancerGoyal, R. / Davis, K. et al. | 2016
- A39
-
Creating an Inventory of Risk Factors for Predicting Stroke among Atrial Fibrillation Patients: A Systematic ReviewOehrlein, E. / Perfetto, E. / Chung, Y. / Ghafoori, P. / Harris, R. et al. | 2016
- A39
-
Examining Uncertainty around the American College of Medical Genetics Recommendation for Newborn Screening for 2-Methylbutyryll-Coa Dehydrogenase Deficiency (2mbg)Algatan, R. / Rittenhouse, B. et al. | 2016
- A40
-
Insulin and Higher Odds of a Positive History of Cardiovascular Disease among Diabetic IndividualsCJ, G. / RE, D. et al. | 2016
- A40
-
Examining the Mortality and Readmission Rates of Patients Diagnosed with Stroke in the United States Medicare PopulationBashyal, R. / Du, H. / Wang, L. / Yuce, H. / Baser, O. et al. | 2016
- A40
-
Accelerated/Malignant Hypertension with a Diagnostic Ambugity: A Retrospective Cohort StudySrujitha, M. et al. | 2016
- A40
-
Prevalence of Inappropriate Prescribing of Antithrombotic Therapy in Ethiopian Elderly Population using Updated 2015 Stopp/Start CriteriaGetachew, H. / Bhagavathula, A. / Befekadu, T. / Admasu, S. et al. | 2016
- A40
-
Mono- And Combination Antihypertensive Therapy with Olmesartan is Associated with Enteropathy RiskAli, A. et al. | 2016
- A41
-
Aspirin Versus Clopidogrel in Prevention of Ischemic Stroke Recurrence: An Evaluation of Effectiveness and Safety from Beijing Medical Insurance DatabaseYang, L. / Wen, L. / Wu, J. et al. | 2016
- A41
-
Characterization of Statin Effectiveness using Real-World Data in a Canadian PopulationShojaie, S. / McCurdy, S. / Thiele, S. / Ching Chau, L. / Martin, L. / Charland, K. / Dobson-Belaire, W. / Duclos, M. / Borrelli, R. et al. | 2016
- A41
-
Comparative Effectiveness of Acei Versus Arb in Elderly Patients with Heart FailureRamachandran, S. / Yang, Y. et al. | 2016
- A41
-
Effectiveness of Therapeutic Water-Only Fasting in Lowering Blood Pressure: A ReviewEziyi, A. et al. | 2016
- A41
-
Impact of Therapeutic Guidelines on Utilization Pattern of Low Molecular Weight Heparins at a South Indian Tertiary Care Teaching HospitalAdepu, R. / Ariyappallil, A. / G, S. et al. | 2016
- A41
-
Comparative Effectiveness and Safety of NOVEL ORAL ANTICOAGULANTS (NOACS) VERSUS VITAMIN K ANTAGONISTS (VKA) in Atrial Fibrillation: A Meta-Analysis of Observational StudiesAlmutairi, A. / Zhou, L. / Lee, J. / Marion, S. / Martin, J. / Lo-Ciganic, W. et al. | 2016
- A42
-
Adherence to Dabigatran and the Risk of StrokeCheetham, T. / Bider-Canfield, Z. / Reynolds, K. et al. | 2016
- A42
-
Trends in Er Visits Due to Hyperkalemia in the United StatesAggarwal, S. / Topaloglu, H. et al. | 2016
- A42
-
Liver Function Status among us Adults having both Hyperlipidemia and Hyperglycemia: A Cross Sectional StudySakharkar, P. / Deb, S. et al. | 2016
- A42
-
Systematic Review of Burden of Hyperkalemia due to Angiotensin Enzyme Converting InhibitorsAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2016
- A42
-
Use of Real-World Data to Estimate Prevalence of Commercially-Insured High Cardiovascular Risk Patients in the United StatesHardin, J. / Quek, R. / Roehl, K. / Richhariya, A. / Gandra, S. et al. | 2016
- A42
-
Trends in the Utilization of Warfarin and Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial FibrillationAlalwan, A. / Voils, S. / Hartzema, A. et al. | 2016
- A43
-
Depression and Coronary Heart Disease Risk: An Overview of Systematic ReviewsReyes, J. / Gutierrez-Ardila, M. / Lopez-Cabra, C. et al. | 2016
- A43
-
Relationship between Lipoprotein(A) and Cardiovascular Events: A Systematic ReviewQuek, R. / Forbes, C. / Deshpande, S. / Worthy, G. / Wolff, R. / Stirk, L. / Kleijnen, J. / Gandra, S. / Djedjos, S. / Wong, N. et al. | 2016
- A43
-
Cardiovascular Risks of Exogenous Testosterone use among Men: A Systematic Review and Meta-AnalysisAlexander, G. / Iyer, G. / Lucas, E. / Lin, D. / Singh, S. et al. | 2016
- A43
-
Variation in Medication Adherence across the Health Care System in Comparative-Effectiveness Research StudiesFranklin, J. / Donneyong, M. / Desai, R. / Markson, L. / Girman, C. / McKay, C. / Patel, M. / Mavros, P. / Schneeweiss, S. et al. | 2016
- A43
-
Association between Exogenous Testosterone and Cardiovascular Events: An Overview of Systematic ReviewsOnasanya, O. / Iyer, G. / Lucas, E. / Singh, S. / Alexander, C. et al. | 2016
- A44
-
Mortality and Rehospitalization Rates among Hospitalized Congestive Heart Failure Patients in the United States Medicare PopulationPandya, S. / Du, H. / Wang, L. / Yuce, H. / Baser, O. et al. | 2016
- A44
-
Pharmacoeconomic Analysis of Naftidrofuryl for Ischemic Stroke TreatmentBelousov, D. / Cheberda, A. et al. | 2016
- A44
-
Simultaneous Coronary Artery Bypass Grafting and Carotid EndarterectomyAvdeyev, A. / Tabarov, A. / Sharip, B. / Zhanabekova, L. / Gizatullina, A. et al. | 2016
- A44
-
Pharmacoeconomic Analysis of Naftidrofuryl in Patients with Chronic Obliterating Diseases of Lower Limb ArteriesBelousov, D. / Cheberda, A. et al. | 2016
- A44
-
Economic Impact of Treatment with Novel oral Anticoagulants Versus Warfarin in Brazilian Private Health SystemFerreira, C. / Squiassi, H. / Ed, P. / Nogueira, F. / Santana, C. / Paiva, E. et al. | 2016
- A44
-
Economic Burden of Unmanaged Chronic Cardiovascular Diseases in Brazilian Supplementary Health Care PerspectiveFerreira, C. / Santana, C. / Squiassi, H. / Ed, P. / Paiva, E. et al. | 2016
- A45
-
Costs Associated with Choice of Perioperative Intravenous Crystalloid among Adults Undergoing Cardiac SurgeryRaghunathan, K. / Khangulov, V. / Peyerl, F. / Shaw, A. et al. | 2016
- A45
-
Impact of a Limb Salvage Program on the Economic Burden of Amputation in The United StatesPalli, S. / Gunnarsson, C. / Kotlarz, H. / Martinsen, B. / Zhao, R. / Rizzo, J. et al. | 2016
- A45
-
Clinical and Economic Burden of Peripheral Artery Disease Among Patients Receiving Endovascular Interventions: A Retrospective Cohort Study of Commercially Insured Patients in the United StatesMeyers, J. / Chaudhari, P. / Madhwani, S. / Candrilli, S. et al. | 2016
- A45
-
An Incremental Cost Analysis of Orbital Atherectomy Plus Angioplasty Compared To Angioplasty Alone for the Treatment of Critical Limb IschemiaZhao, R. / Gunnarsson, C. / Kotlarz, H. / Martinsen, B. / Palli, S. / Bell, E. / Rizzo, J. et al. | 2016
- A45
-
Health Care Costs among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and WarfarinDeitelzweig, S. / Laliberté, F. / Raut, R. / Germain, G. / Bookhart, B. / Olson, W. / Schein, J. / Lefebvre, P. et al. | 2016
- A46
-
Examination of the Economic Burden of Dyslipidemia in the Veterans Health Administration PopulationKeshishian, A. / Tan, H. / Xie, L. / Baser, O. et al. | 2016
- A46
-
Real-World Costs of Ischemic Stroke by Discharge StatusMu, F. / Hurley, D. / Betts, K. / Messali, A. / Paschoalin, M. / Wu, E. et al. | 2016
- A46
-
Annual Fatal and Non-Fatal Cardiovascular Event Costs among Non-Elderly Commercially Insured Adults with Hyperlipidemia in the United StatesBonafede, M. / Johnson, B. / Paoli, C. / Gandra, S. et al. | 2016
- A46
-
Evaluating the Economic Burden and Health Care Utilization of Coronary Artery Disease in the Us Medi-Cal PopulationZhang, Q. / Zhao, Y. / Keshishian, A. / Xie, L. / Yuce, H. / Baser, O. et al. | 2016
- A46
-
Cost Study of Cardiovascular DiseasesGantugs, Y. et al. | 2016
- A46
-
Retrospective Analysis of the Economic Burden of Patients Diagnosed with Congestive Heart Failure in the California Medicaid PopulationOgbomo, A. / Zhao, Y. / Kariburyo, M. / Xie, L. / Yuce, H. / Baser, O. et al. | 2016
- A47
-
Cost-Effectiveness Analysis of Antihypertensive Combination Therapy among Patients with Moderate to Severe HypertensionWang, X. / Abughosh, S. et al. | 2016
- A47
-
Cost Effectiveness of Apixaban (Novel Oral Anti-Coagulant) Compared with Conventional Therapy for Stroke Prophylaxis among Renal Impaired Patients with Atrial-Fibrillation from Perspective of Us Third Party PayerKumar, A. / Wu, W. / Nili, M. et al. | 2016
- A47
-
Cost Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in United States Population: Results of the Improve-It TrialAlmalki, Z. / Guo, J. et al. | 2016
- A47
-
Operating Room Variable Cost of Transcatheter Aortic Valve ReplacementClancy, S. / Womeldorff, J. / Ryan, M. et al. | 2016
- A47
-
Cost Consequence Analysis of Two Different Active Flowable Hemostatic Matrices in Cardiac Surgery Patients (Us Hospital Provider Perspective)Makhija, D. / Rock, M. / Xiong, Y. / Ikeme, S. / Rubinstein, M. / Arnold, M. et al. | 2016
- A48
-
Clinical Events Avoided with Apixaban Compared to Edoxaban for the Initial Treatment and Prevention of Venous ThromboembolismLanitis, T. / Hamilton, M. / Quon, P. / Browne, C. / Cohen, A. et al. | 2016
- A48
-
Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular EventsLee, H. / Watkins, J. / Danielson, D. et al. | 2016
- A48
-
Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure: The Case of IvabradineIliza, A. / Fanton Aita, F. / Mitchell, D. / Guertin, J. / Matteau, A. / Lelorier, J. et al. | 2016
- A48
-
Cost Effectiveness Analysis Apixaban in the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement in Adults in Costa Rica in 2015Peralta-Acon, M. / Poveda-Fernandez, J. et al. | 2016
- A48
-
Reevaluating the Value of Ezetimibe in the United States For Patients with History of Cvd Based on the Improve-It ResultDavies, G. / Baxter, C. / Vyas, A. et al. | 2016
- A48
-
The Real-World Cost-Effectiveness of Coronary Artery Bypass Grafting Versus Stenting in High-Risk Patients: Propensity Score Analysis of a Single Centre ExperienceAriyaratne, T. / Ademi, Z. / Huq, M. / Duffy, S. / Billah, B. / Rosenfeldt, F. / Parkinson, B. / Yap, C. / Yan, B. / Smith, J. et al. | 2016
- A49
-
Health Care Resource Utilization and Cost among Pulmonary Arterial Hypertension Patients Before and After Sequential Combination Therapy InitiationBurger, C. / Ozbay, B. / Riehle, E. / Montejano, L. / White, R. et al. | 2016
- A49
-
Health Economic Impact of Angiographic Risk Features in Pci PatientsFan, W. / Mitchell, M. / Plent, S. / Deliargyris, E. et al. | 2016
- A49
-
Indirect Costs Associated with Cardiovascular Disease in Canada: A Literature ReviewBall, G. / Campbell, K. / Burke, N. / Pericleous, L. / Tarride, J. et al. | 2016
- A49
-
Price Elasticity of Demand for New Oral Anticoagulant Agents among Patients with Non-Valvular Atrial FibrillationLiu, S. / Jackson, J. / Khalaf, K. / Meyer, K. / Brown, D. et al. | 2016
- A49
-
Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United StatesHarrington, R. / Zueger, P. / Kumar, V. / Rigoni, G. / Atwood, A. / DiDomenico, R. / Touchette, D. et al. | 2016
- A50
-
Patterns and Predictors of Discontinuation and Switch in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral AnticoagulantsYao, X. / Shah, N. / Sangaralingham, L. / Gersh, B. / Noseworthy, P. et al. | 2016
- A50
-
Effect of Patient-Reported Symptoms on Medication Adherence in Hypertensive PatientsFu, M. / Mehas, N. / Jaynes, H. / Hudmon, K. / Zillich, A. et al. | 2016
- A50
-
Hospital Utilization in Patients Diagnosed with Peripheral Arterial HypertensionBelk, K. / Craver, C. / Voorhees, C. / Chang, D. et al. | 2016
- A50
-
Estimating the Cost Per Percent Point Reduction in Ldl-C for Patients Treated with Pcsk9 Inhibitors in a Large National Health PlanGitlin, M. / Patel, J. / Burton, T. / Seare, J. / Whang, J. / Harrison, D. et al. | 2016
- A50
-
Adherence, Compliance, and Persistence with Lipid-Lowering Therapies: A Systematic ReviewXu, Y. / Worden, C. et al. | 2016
- A50
-
Persistence and Compliance with Cardiovascular Drug Therapy Among SeniorsRioux, J. / Hunt, J. et al. | 2016
- A51
-
Impact of Depression on Health Status and Health Care Utilization in Patient with HypertensionShao, H. / Mir, M. / Ye, X. / Thomas, N. / Babazadeh, S. et al. | 2016
- A51
-
How do utilities vary for cardiovascular events? A systematic reviewBlieden, M. / Szatkowski, A. / Cheng, L. / Paoli, C. / Gandra, S. et al. | 2016
- A51
-
Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial FibrillationBarrett, A. / DiBenedetti, D. / Phatak, H. / Masseria, C. / Kamble, S. et al. | 2016
- A51
-
Assessment of Adherence to Hypertension Treatment in Primary Care Physician in UkraineKorzh, O. et al. | 2016
- A51
-
Comparison of Persian Version of the Hill-Bone and Morisky Medication Adherence Scales in Hypertensive PatientsSaleh, S. / Gholami, K. / Sarayani, A. / Jahangard-rafsanjani, Z. / Hadjibabaie, M. / Rajabi, M. / Morisky, D. et al. | 2016
- A52
-
Hypertrophic Cardiomyopathy: A Heart Burden and Challenging DiagnosisSalberg, L. / Schroeder, E. / McKinley, G. et al. | 2016
- A52
-
Reported Psychological Symptoms and Quality of Life in Patients Suffering an Acute Coronary Syndrome: New Insights from the Pgrx-3 Real-World DatasetCuervo, J. / Nordon, C. / Rossignol, M. / Morisot, N. / Worsfold, A. / Benichou, J. / Danchin, N. / Abenhaim, L. / Grimaldi, L. et al. | 2016
- A52
-
Development and Content Validation of a Patient-Reported Outcome Measure to Evaluate Statin Intolerance in the Real WorldJacobson, T. / Edelman, S. / Davidson, M. / Galipeau, N. / Shields, A. / Mallya, U. / Koren, A. et al. | 2016
- A52
-
Health-Related Quality of Life of Patients Suffering an Acute Coronary Syndrome: An Analysis Using Multinational Eq-5d Outcomes from the Pgrx-3 Real-World DatasetCuervo, J. / Nordon, C. / Rossignol, M. / Morisot, N. / Worsfold, A. / Benichou, J. / Danchin, N. / Abenhaim, L. / Grimaldi, L. et al. | 2016
- A52
-
Clinical Outcomes and Quality of Life After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in ArmeniaMinasyan, K. / Thompson, M. / Abrahamyan, L. et al. | 2016
- A53
-
Identification and Management of Canadian Patients with Symptoms of Statin Intolerance: Results from a Real-World Clinical Practice SurveyOh, P. / Hovingh, G. / Gandra, S. / McKendrick, J. / Dent, R. / Wieffer, H. / Catapano, A. / Rosenson, R. / Stroes, E. et al. | 2016
- A53
-
Identification and Management of Patients with Symptoms of Statin Intolerance: Results from A Survey of Brazilian CliniciansMcKendrick, J. / Gandra, S. / Hovingh, G. / Dent, R. / Wieffer, H. / Catapano, A. / Oh, P. / Rosenson, R. / Stroes, E. et al. | 2016
- A53
-
A Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and other Lipid-Lowering Therapies for the Management of Lipid Levels in HyperlipidemiaWorthy, G. / Gandra, S. / Worth, G. / Dent, R. / Forbes, C. / Deshpande, S. / Cheng, L. / Ross, J. / Kleijnen, J. et al. | 2016
- A53
-
A Graphical and Analytics Approach to Understanding Hospital Readmissions in North CarolinaSaunders, W. / Blanchette, C. et al. | 2016
- A53
-
Identifying and Managing Patients with Symptoms of Statin Intolerance: Results from a Survey of Clinicians in the United StatesRosenson, R. / Gandra, S. / McKendrick, J. / Dent, R. / Wieffer, H. / Catapano, A. / Oh, P. / Hovingh, G. / Stroes, E. et al. | 2016
- A54
-
Regional Variations in us Hospital Utilization of GP IIB/IIIA InhibitorsFan, W. / Werner, R. / Mitchell, M. et al. | 2016
- A54
-
Estimating the Future Burden of Cardiovascular Disease in China and the Potential Value of Universal Lipid and Blood Pressure ControlStevens, W. / Peneva, D. / Li, J. / Liu, L. / Liu, G. / Gao, R. / Lakdawalla, D. et al. | 2016
- A54
-
Comparing the Value of Evidence Over Time for Clopidogrel Pharmacogenomics Versus Drug-Drug InteractionsGuzauskas, G. / Serbin, M. / Veenstra, D. et al. | 2016
- A54
-
Impact of Ldl-C Goal Attainments and Cost of Management Following the 2013 Acc/Aha Guideline Among Statin Users in Hong Kong Chinese: Real-World ResultsLee, V. W. / Wang, Y. / Nichol, M. B. / Wu, J. / Tang, H. C. / Mak, C. P. / Yan, B. P. et al. | 2016
- A54
-
Trend and Clinical Characteristics of Statin Initiation in Patients Discharged from Hospital for a New Atherosclerotic Cardiovascular Disease Episode from 2006 to 2012 in Taiwan: A Population-Based StudyHuang, S. / Shau, W. / Lai, C. / Chen, S. / Li, J. / Fung, S. / Lai, M. et al. | 2016
- A54
-
Trends in Oral Anticoagulant use in Qatar: A 5-Year ExperienceElewa, H. / Alhaddad, A. / Al-Rawi, S. / Nounou, A. / Mahmoud, H. et al. | 2016
- A55
-
Racial Disparities in Amputation Rates Among Native Americans with Peripheral Artery Disease: Analysis of the Health Care Cost and Utilization Project DatabaseRizzo, J. / Chen, J. / Laurich, C. / Santos, A. / Martinsen, B. / Ryan, M. / Kotlarz, H. / Gunnarsson, C. et al. | 2016
- A55
-
Bolus Plus Infusion Remains Predominant Mode of GP IIB/IIIA Utilization: A 2015 us Hospital Purchasing StudyMitchell, M. / Smith, C. / Werner, R. et al. | 2016
- A55
-
Racial Disparities in Amputation Rates for Patients with Peripheral Artery Disease: Long-Term Trends and Projections to 2020Rizzo, J. A. / Chen, J. / Kotlarz, H. / Martinsen, B. / Ryan, M. P. / Palli, S. / Gunnarsson, C. et al. | 2016
- A55
-
Demographic and Socioeconomic Characteristics that Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation PatientsKeshishian, A. / Du, J. / Xie, L. / Yuce, H. / Baser, O. et al. | 2016
- A55
-
Racial Disparities in Amputation Rates for the Treatment of Peripheral Artery Disease Using the Health Care Cost and Utilization Project DatabaseRizzo, J. / Chen, J. / Kotlarz, H. / Ryan, M. / Gunnarsson, C. et al. | 2016
- A56
-
Outcomes related to variation in hospital pulmonary embolus observation stay utilizationWeeda, E. / Bunz, T. / Coleman, C. / Schein, J. / Crivera, C. / Wildgoose, P. / Peacock, W. / Fermann, G. et al. | 2016
- A56
-
Variation in Irish GMS Pharmaceutical Expenditure by ATC ClassificationConwayLenihan, A. / Woods, N. / Ahern, S. / Moore, S. / Cronin, J. et al. | 2016
- A56
-
Co-Occurring Chronic Conditions and the Economic Burden Among Community-Dwelling Stroke Survivors in the United States: A Propensity Score Matched AnalysisChinthammit, C. / Nimworapan, M. / Bhattacharjee, S. et al. | 2016
- A56
-
Antihypertensive and Antilipemic Medication use and Emergency Room Expenditures Among Adults with Coexisting Hypertension and HyperlipidemiaChopra, I. / Sambamoorthi, U. et al. | 2016
- A56
-
Statin Selection in Qatar Based on Multi-Indication Pharmacotherapeutic Multi-Criteria Scoring Model and Clinician PreferenceAl-Badriyeh, D. / Fahey, M. / Al-Khal, A. / Zaidan, M. et al. | 2016
- A57
-
Age- And Gender- Specific in Direct Hospitalization Costs for Hemorrhagic Stroke Inpatients with Basic Medical Insurance Scheme for Employees in ChinaMa, Y. / Xiong, X. / Li, J. / Jie, Z. / Fang, Y. et al. | 2016
- A57
-
PCSK9 Inhibitors - Alirocumab and Evolucumab: Key Insights on Differentiation in a Generic MarketKochel, S. / Mwamburi, M. et al. | 2016
- A57
-
Demographic Variance of Inpatient Hospitalizations from Stroke in the State of Missouri from 2000-2012Behera, A. / Vogt, C. / Armbrecht, E. et al. | 2016
- A57
-
Burden of Cerebrovascular Disease in ColombiaLasalvia, P. / Otálora, M. / Castañeda-Cardona, C. / Cifuentes, E. / Soto, C. / Guerrero, J. / García, C. / Arias, J. / Rosselli, D. et al. | 2016
- A57
-
The Presence of Mental Health Conditions Among Patients with Congestive Heart Failure and the Impact on Health Outcomes: A Propensity Score Matched StudyBhattacharya, R. / Ruble, M. / Renda, A. M. / Gresky, D. / Trevino, L. et al. | 2016
- A57
-
The Uptake of Non-Vitamin K Oral Anticoagulants in Ireland: Balancing Cost-Effectiveness Analysis and Budget ImpactBarry, M. / Clarke, S. / Geraghty, N. et al. | 2016
- A58
-
A Comparison of Cardiovascular Drugs Approved by the Us Food and Drug Administration and Health Canada (1980-2014)Alasmari, M. S. / Seoane-Vazquez, E. / Eguale, T. / Szeinbach, S. et al. | 2016
- A58
-
Who were the early adopters of dabigatran? An application of group-based trajectory modelsLo-Ciganic, W. / Gellad, W. / Hiskamp, H. / Choudhry, N. / Zhang, R. / Chang, C. / Jones, B. / Richards-Shubik, S. / Guclu, H. / Donohue, J. et al. | 2016
- A58
-
Changes in the Use of Prescription and Over-the-Counter Medications and Dietary Supplements in the United States: 2005 Versus 2011Qato, D. / Wilder, J. / Schumm, P. / Alexander, C. et al. | 2016
- A58
-
low Density Lipoprotein Cholesterol Levels Among Patients with Clinical Atherosclerotic Cardiovascular Disease and Heterozygous Familial Hypercholesterolemia Post Statin TherapyJohnson, B. / Bonafede, M. / Princic, N. / Harrison, D. / Boatman, B. / Patel, J. et al. | 2016
- A58
-
Assessment of Disease-State Knowledge in Hypertensive Patients in Quetta, Pakistanul Haq, N. / Fatima, A. / Nasim, A. / Razaq, G. / Ahmed, N. / Zeeshan, M. / Mohammad, S. et al. | 2016
- A59
-
Predictive Model Of Parkinson’s Disease In Large Electronic Health Records DatabaseKabadi, S. / Lee, A. / Kuhn, M. / Gray, D. et al. | 2016
- A59
-
Treatment Patterns Among Patients Prescribed Pde-5 Inhibitor Monotherapy for Pulmonary HypertensionYeaw, J. / Lickert, C. / Drake, W. / De, A. / Wade, R. et al. | 2016
- A59
-
Linguistic Validation of the Free and Cued Selective Reminding Test with Immediate Recall (FCSRT-IR) In 3 Languages for 3 Countries with Alzheimer’s Disease PatientsBrandt, B. / McKown, S. / Gawlicki, M. / Yohe Moore, E. et al. | 2016
- A59
-
Severity Of Memory Impairment And Functional Limitations In The United States And Association With Health Care Resource Use: An Nhanes AnalysisSanon Aigbogun, M. / Stellhorn, R. / Krasa, H. / Kostic, D. et al. | 2016
- A59
-
Psychiatric Safety Profile Of Suvorexant, A First-In-Class Orexin Receptor AntagonistAli, A. et al. | 2016
- A60
-
A Network Meta-Analysis on Comparative Efficacy and Safety Of Investigational and Approved Therapies for the Treatment of NarcolepsyTaneja, A. / Saharia, P. / Chadha, N. / Rajput, A. / Goel, A. et al. | 2016
- A60
-
Hospitalization Burden Associated with Chronic Inflammatory Demyelinating Polyneuropathy in the United StatesSuryavanshi, M. / Khanna, R. et al. | 2016
- A60
-
A Systematic Review of Benzodiazepine use for the Treatment of Seizure EmergenciesHaut, S. / Seinfeld, S. / Pellock, J. / Halvorsen, M. et al. | 2016
- A60
-
Can indirect comparison methods mitigate evolving trial populations in adjunctive antiepileptic drug trials? A propensity-score matched indirect comparison of brivaracetam and levetiracetamSwallow, E. / Fang, A. / Signorovitch, J. / Plumb, J. / Borghs, S. et al. | 2016
- A60
-
Rapid Relief of Pain in Episodic Migraine was Associated with Lower Self-Reported Disability and Lower Rates of Migraine-Associated Symptoms: A Secondary Analysis of the Compass TrialWallick, C. / Aggarwal, S. / Yonan, C. / Shulman, K. et al. | 2016
- A61
-
Budgetary Impact Analysis of Levetiracetam use for Focal Epilepsy Patients’ Treatment with or without Secondary Generalization from the Brazilian Public Health System PerspectiveCarmo, E. / Nita, M. / Motta, R. / Lima, F. et al. | 2016
- A61
-
Antiepileptic Drugs, Risk of Suicide Attempts, and the Impact of Underlying Medical Conditions: Results from the Pgrx Information SystemGrimaldi, L. / Nordon, C. / Rossignol, M. / Rouillon, F. / Kurz, X. / Abenhaim, L. et al. | 2016
- A61
-
Cost-Utility Analysis of Dimethyl Fumarate as a First Switch Treatment for Relapsing Remitting Multiple Sclerosis in the Brazilian Public Health Care SystemFahham, L. / Murta, L. / Teich, V. / Machado, M. / Serafini, P. et al. | 2016
- A61
-
Health Care Utilization and Costs in Treated and Non-Treated Patients Newly Diagnosed with Alzheimer’s Disease in the United StatesSanon, M. / Xie, L. / Bent-Ennakhil, N. / Hartry, A. / Wang, Y. / Kariburyo, M. / Neumann, P. / Fillit, H. et al. | 2016
- A61
-
Burden of Disease and Health Care Costs of Patients Over 50 with Parkinson’s Disease in a Big Real-World Database (ARCO)Pedrini, A. / Dondi, L. / Calabria, S. / Rielli, R. / Martini, N. et al. | 2016
- A61
-
Finding Potential Predictors of Alzheimer’s Disease Using Medicare Claims DataMiyasato, G. / Zhang, Q. / Wang, Z. / Small, D. / Chiu, G. et al. | 2016
- A62
-
Hospitalization Cost of Chiari Malformation Type I Surgery in PediatRIC PatientsPan, I. / Mayer, R. / Luerssen, T. / Lam, S. et al. | 2016
- A62
-
Price Analysis of Multiple Sclerosis Disease-Modifying Drugs: Comparison Between Saudi Arabia and the United StatesBin Sawad, A. / Alkelya, M. et al. | 2016
- A62
-
Antiepileptic Drug Pill Burden During the First Year Following Monotherapy Initiation Associated with Increased Epilepsy Costs in the United StatesVelez, F. / Korsnes, J. et al. | 2016
- A62
-
Cost-Effectiveness of Different Strategies for Treatment of Relapsing-Remitting Multiple SclerosisBin Sawad, A. / Seoane-Vazquez, E. / Rodriguez-Monguio, R. / Turkistani, F. et al. | 2016
- A62
-
Projecting the Potential Cost Effectiveness of Ocrelizumab Versus Standard Care in Primary Progressive Multiple Sclerosis Patients Under Alternative Pricing ScenariosSuh, K. / Carlson, J. / Garrison, L. et al. | 2016
- A62
-
Cost And Resource Utilization Associated with Hospitalized Multiple Sclerosis PatientsCraver, C. / Belk, K. / Ernst, F. et al. | 2016
- A63
-
A Cost-Utility Analysis of First-Line Treatment in Neuropathic Pain: Pregabalin Versus VenlafaxineLe, D. / Born, A. / Brinkerhoff, A. / Vaidya, V. et al. | 2016
- A63
-
Examining the Association Between Epilepsy Seizure Frequency and Health Economic Outcomes Among CaregiversHelmers, S. / Gupta, S. / Knoth, R. et al. | 2016
- A63
-
Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in ColombiaOrdoñez, J. / Delgado, A. et al. | 2016
- A63
-
Economic and Clinical Evaluation of Electrostimulation in Medical RehabilitationKamensky, V. / Sebek, M. / Svobodova, R. / Gajdos, O. / Rogalewicz, V. et al. | 2016
- A63
-
Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease in Brazilda Silva, L. et al. | 2016
- A64
-
Adherence and Persistence to Oral Migraine Prophylaxis Medications in Patients with Chronic MigraineWong, J. / Stock, E. / Godley, P. / Mbagwu, G. / Campbell, K. / Noble, S. / Yehoshua, A. et al. | 2016
- A64
-
Loss Productivity and Quality of Life in Parkinson’s DiseaseMarquez, M. / Sanchez, K. / Guzman, S. / Soto, H. / De Sarachaga, A. / Cervantes, A. / Rodriguez, M. et al. | 2016
- A64
-
Estimating the out-of-Pocket Expenses and Transport, Caregiver, Home Adaptation and or Special Equipment Acquisition Costs Associated with Parkinson’s DiseaseMarquez, M. / Sanchez, K. / Guzman, S. / Soto, H. / De Sarachaga, A. / Cervantes, A. / Rodriguez, M. et al. | 2016
- A64
-
Treatment with interferon beta-1a in brazil is associated with fewer hospitalizations due to relapse, better adherence and a better response compared to other platform therapiesSerafini, P. / Pike, J. / Jones, E. / Machado, M. et al. | 2016
- A64
-
Manager, Health Economics and Patient AccessHaddad, P. / Dong, C. / Schecter, R. / Yeung, M. / Duquette, P. et al. | 2016
- A64
-
Emergency Department Treatment Patterns of Patients with Epilepsy in the United States from 2008-2011: A Nationally Representative Analysis using Nhamcs DataOsterhaus, J. / Ning, X. / Petrilla, A. / Agatep, B. / Gilmet, G. et al. | 2016
- A65
-
Cost-sharing and Demand Elasticity on Disease Modifying Therapies in Multiple SclerosisShao, H. / Shi, L. / Stoecker, C. et al. | 2016
- A65
-
Elicitation of Utility Values in Patients with Multiple Sclerosis in South KoreaCHOI, Y. / LIM, S. / Barone, J. / Suh, D. et al. | 2016
- A65
-
A Qualitative Assessment of Multiple Sclerosis Patients’ Experiences with Disease Modifying TherapiesThach, A. / Brown, C. / Herrera, V. / Sasane, R. et al. | 2016
- A65
-
Psychometric Properties of the Euroqol-5-Dimensions Questionnaire (EQ-5D-3L) Among Multiple Sclerosis CaregiversJoshi, N. / Khanna, R. / Bentley, J. / West-Strum, D. / Philips, G. / Strum, M. / Barnard, M. et al. | 2016
- A65
-
Predictors of Activities of Daily Living in Elderly Nursing Home Patients with Parkinson’s DiseaseChekani, F. / Bali, V. / Aparasu, R. et al. | 2016
- A66
-
Deriving Utility Weights from Patient-Reported Outcomes in EpilepsyHendrix, N. / Devine, B. et al. | 2016
- A66
-
A Comparison of EQ-5D-3L and SF-6D Among Caregivers of Individuals with Multiple SclerosisJoshi, N. / Khanna, R. / Bentley, J. / West-Strum, D. / Philips, G. / Barnard, M. / Strum, M. et al. | 2016
- A66
-
Health-Related Quality of Life and Work Productivity in Patients Treated with Onabotulinumtoxina for Cervical Dystonia in a Multicentre, Prospective, Observational Study: PosturePetitclerc, M. / Bhogal, M. / Dhani, S. / Belle Blagrove, L. et al. | 2016
- A66
-
The Burden of Multiple Sclerosis in JapanYamabe, K. / Witt, E. / DiBonaventura, M. et al. | 2016
- A66
-
An Evaluation of Disability Progression and Quality of Life in Multiple Sclerosis Patients in Brazil and MexicoSerafini, P. / Pike, J. / Jones, E. / Machado, M. et al. | 2016
- A66
-
Levodopa/Carbidopa Intestinal Gel Treatment and Its Impact on Quality of Life and Work Ability in Patients with Parkinson’s Disease in Czech RepublicPoliakova, N. / Lipovska, S. / Bielik, J. / Melus, V. / Midler, M. / Liptakova, A. et al. | 2016
- A67
-
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple SclerosisLin, P. / Saret, C. / Neumann, P. / Sandberg, E. / Cohen, J. et al. | 2016
- A67
-
Gender Differences In The Use Of Complementary And Alternative Medicine In Adults With Migraines/Severe Headaches In The United StatesRhee, T. / Bechtol, R. / Harris, I. / Rodriguez, R. et al. | 2016
- A67
-
A Life-Course Assessment Of Medication Use And Medical Costs Of Lennox-Gastaut Syndrome (Lgs)Montouris, G. / Piña-Garza, J. / Vekeman, F. / Cheng, W. / Tuttle, E. / Giguere-Duval, P. / Duh, M. / Isojarvi, J. et al. | 2016
- A67
-
A Systematic Review of the Impact of Adjuvant Antiparkinson Medications on Disability and Quality of Life of Patients with Parkinson’s DiseaseChekani, F. / Bali, V. / Aparasu, R. / Mullen, P. et al. | 2016
- A67
-
Gender-Specific Impact Of Hta Bodies On Drug Prescriptions: Evidence From Alzheimer’s Disease Drugs In FranceChauvin, P. / Sirven, N. / Rapp, T. / Bellanger, M. et al. | 2016
- A68
-
Prevalence, Patterns, And Predictors Of Psychotropic Polypharmacy Among Community-Dwelling Elderly Individuals With Parkinson’s Disease In The United StatesBhattacharjee, S. / Goldstone, L. / Bhattacharya, R. / Warholak, T. et al. | 2016
- A68
-
The Use Of Migraine Prophylaxis Treatment: Analysis Of Clinical Practice Data From The United States, Germany, France, And JapanMutebi, A. / Pike, J. / Shah, N. / Jackson, J. / Cotton, S. / Desai, P. / Sapra, S. et al. | 2016
- A68
-
Drug Utilization Evaluation Of Antiepileptic Drugs In Pediatric Population At A Secondary Care HospitalNalluri, K. et al. | 2016
- A68
-
Comparison Of Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Subcutaneously Administered Disease Modifying Therapies: Interferon Beta 1b Versus 1aGreene, M. / Greene, N. et al. | 2016
- A68
-
Characterizing Patient-Reported Health-Related Quality-Of-Life Measures Among Users And Non-Users Of Migraine Prophylaxis Treatment: An Analysis Of Clinical Practice Data From The United States, Germany, France, And JapanShah, N. / Mutebi, A. / Pike, J. / Jackson, J. / Cotton, S. / Desai, P. / Sapra, S. et al. | 2016
- A68
-
Factors Associated With A History Of Failure And Switching Migraine Prophylaxis Treatment: An Analysis Of Clinical Practice Data From The United States, Germany, France, And JapanPike, J. / Mutebi, A. / Shah, N. / Jackson, J. / Cotton, S. / Desai, P. / Sapra, S. et al. | 2016
- A69
-
Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying DrugsKozma, C. / Munschauer, F. / Phillips, A. et al. | 2016
- A69
-
Fingolimod Versus Teiflunomide: Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies In The United StatesGreene, M. / Greene, N. et al. | 2016
- A69
-
Impact Of New Entrants To The Market For Multiple-Sclerosis Disease-Modifying Drugs In CanadaBennetts, L. / Khoury, H. / O’Neil, B. et al. | 2016
- A69
-
Health Economic Evaluation Of Interferon Beta 1b Versus 1a For Patients Diagnosed With Relapsing Remitting Multiple SclerosisGreene, M. / Greene, N. et al. | 2016
- A69
-
Health Economic Evaluation Of Orally Versus Subcuteanously Administered Disease Modifying Therapies For Patients Diagnosed With Relapsing Remitting Muliple SclerosisGreene, M. / Greene, N. et al. | 2016
- A70
-
Fingolimod Versus Teiflunomide: Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Oral Disease Modifying TherapiesGreene, M. / Greene, N. et al. | 2016
- A70
-
Current Status Of Multiple Sclerosis In ColombiaJiménez-Pérez, C. / Zarco-Montero, L. / Castañeda-Cardona, C. / Otálora-Esteban, M. / Martínez, A. / Rosselli, D. et al. | 2016
- A70
-
Orals Versus Subcutaneous Administration Of Disease Modifying Therapies: A Comparison Of Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple SclerosisGreene, M. / Greene, N. et al. | 2016
- A70
-
Predictors And Prevalence Of Sleep Disturbance And Hypnotic Use In Persons With CancerScalo, J. / Rascati, K. et al. | 2016
- A70
-
A Retrospective Study Of United States Health Care Utilization And Costs For Patients With Multiple Sclerosis Treated With Disease-Modifying TherapySelzer, M. / Hashemi, L. et al. | 2016
- A70
-
Trends In Design, Conduct, And Outcomes Measures For Patient Registries For Multiple SclerosisAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2016
- A71
-
Assesment of the Medical and Social Benefits of Incretin-Based TherapyPetrova, G. / Zaharieva, S. / Carukciev, D. et al. | 2016
- A71
-
Do Accepted Techniques for Indirect Comparative Effectiveness Reflect the need for Individualized Patient Care in Heterogeneous Populations? The Case of Brivaracetam Versus Adjunctive Antiepileptic Medications for the Treatment of Adult Patients with Focal SeizuresBorghs, S. / Harvey, R. / Srivastava, K. / Townsend, R. / Charokopou, M. et al. | 2016
- A71
-
Incidence of Prescribing Errors in Hospitalized Patients in Saudi ArabiaMahmoud, M. / Aljadhey, H. / Hassali, M. et al. | 2016
- A71
-
Treatment Patterns Of Antiepileptic Drugs In Patients With Potential Refractory Epilepsy In The Texas Medicaid ProgramGupte-Singh, K. / Wilson, J. / Barner, J. / Hovinga, C. / Rascati, K. / Richards, K. et al. | 2016
- A71
-
Cross-Cultural Validation of Four Commonly used Symptoms Based Questionnaires to Assess Neuropathic Pain in Patients with Chronic PainGudala, K. / Bansal, D. / Ghai, B. et al. | 2016
- A72
-
Morbidity Endpoints (ME) in the Amnog Process in Germany: Are me Less Important in Oncology Substances?Bakker, K. / Volmer, T. et al. | 2016
- A72
-
Development of a Systematic Review Search Filter to Identify Medication Adherence StudiesJohnson, N. / Tongbram, V. / Ndirangu, K. / Ogden, K. / Bay, C. et al. | 2016
- A72
-
A Review Evaluating the Validity of Smartphone Sensors and Components to Measure Clinical Outcomes in Clinical ResearchByrom, B. / Lee, J. / McCarthy, M. / Muehlhausen, W. et al. | 2016
- A72
-
Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular OutcomesFerrières, J. / Dallongeville, J. / Getsios, D. / Rossignol, M. / Abenhaim, L. / Grimaldi-Bensouda, L. / Amzal, B. et al. | 2016
- A72
-
How to Measure ‘Opioid Relapse’ in Real-World Claims DataMontejano, L. / Ronquest, N. / Willson, T. / Wollschlaeger, B. / Cole, A. / Nadipelli, V. et al. | 2016
- A73
-
Are Meaningful Discussions About Adherence in Reimbursement Submissions of Chronic Diseases Hindered by Reporting Heterogeneity?Quigley, J. / Halfpenny, N. / Ward, K. / O’Rourke, J. / Thompson, J. / Scott, D. et al. | 2016
- A73
-
Comparing the Expanded Disability Status Scale Versus the Multiple Sclerosis Functional Composite As Clinical Endpoints in Multiple Sclerosis Clinical Trials: A Quantitative Meta-AnalysisBin Sawad, A. / Seoane-Vazquez, E. / Rodriguez-Monguio, R. / Turkistani, F. et al. | 2016
- A73
-
A Prevalence Study on Gestational Hypertension and Associated Complications in Pregnant WomenAhmad, M. / Masood, I. / Usman Minhas, M. / Noman ul Haq, N. et al. | 2016
- A73
-
Evaluation of Different Rules for Line of Therapy (LOT) Assignment in Non-Small Cell Lung Cancer (NSCLC) PatientsFeinberg, B. / Laney, J. / Lal, L. / Mujumdar, U. et al. | 2016
- A73
-
Utilizing a Byod Mobile App to Collect Patient Diaries and Dosing Information in a Phase II Clinical TrialButler, A. / Mui, Y. / Dow, C. et al. | 2016
- A73
-
A Risk Analysis Model to Evaluate Safe Delivery and use of The First Chemotherapy Injection for Home Administration: Omacetaxine MepesuccinateKim, S. / Stemhagen, A. / Barrale, R. / Van Wart Hood, J. / Pathak, A. et al. | 2016
- A74
-
Assessing the Predictive Validity of Quality of Evidence Grades in Systematic Reviews. A Meta-Epidemiological StudyGartlehner, G. et al. | 2016
- A74
-
Timing and Characteristics of Sudden Death in A Patient Population on HemodialysisKumar, P. / Savant, K. / Prabhu, R. et al. | 2016
- A74
-
Benefit-Harm Assessment Using Data Derived from Network Meta-Analysis: An Application using Treatments for Acute Venous ThromboembolismCameron, C. et al. | 2016
- A74
-
Tracking Antipsychotic Polypharmacy and Treatment PatternsLevin, R. / Germsheid, L. et al. | 2016
- A74
-
Incorporating User Experience Design into Electronic Clinical Outcome Assessment System DesignButler, A. / Feaster, T. / Friedberger, G. / Gaughan, S. et al. | 2016
- A74
-
Latest Trends in Design of Clinical Trials for Stroke Treatment with Stem CellsAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2016
- A75
-
Selecting NSCLC Patients for Vaccination: A Causal Inference ApproachLorenzo-Luaces, P. / Sanchez, L. / Saavedra, D. / Alonso, A. et al. | 2016
- A75
-
Current Literature Describing the Clinical Utility and Economic Value of Cancer Molecular DiagnosticsDoshi, S. / Stanek, E. / Mathews, C. / Wat, R. et al. | 2016
- A75
-
Establishing Equivalence of Electronic Clinician-Reported Outcome MeasuresFeaster, T. / Fuller, R. / Mcnamara, C. / Lenderking, W. / Miller, D. / Sabatino, D. / Butler, A. et al. | 2016
- A75
-
Identifying Non-Responders to Brace Therapies in Multiple Sclerosis using Advanced Predictive ModelsRisson, V. / Rigg, J. / Bonzani, I. / Medin, J. / Olson, M. et al. | 2016
- A75
-
Feasibility of Linking Benefit Design and Administrative Claims Data to Evaluate the Impact of Medication Access and Restrictive Formularies Across Multiple Therapeutic AreasHenk, H. / Lopez, J. / Bookhart, B. et al. | 2016
- A75
-
Discrete Event Simulation for Facilitating Between-Study ComparisonsNajafzadeh, M. / Schneeweiss, S. / Choudhry, N. / Wang, S. / Gagne, J. et al. | 2016
- A76
-
One-Size-May-Not-Fit-All: A Reconsideration of Existing Approaches for Estimating Utilities of Multi-MorbidityMujica-Mota, R. / Medina-Lara, A. et al. | 2016
- A76
-
Do Rhinologic Patients have Seasonal Variation in Generic or Disease-Specific Health-Related Quality of Life?Hytönen, M. / Roine, R. / Ruuhela, R. / Sintonen, H. / Virkkula, P. / Ylitalo-Heikkilä, M. et al. | 2016
- A76
-
Responsiveness and Test-Retest Reliability of New Disease Assessment Instruments in Systematic Lupus Erythematosus (SLE) in Relation to Sledai-2KNarayanan, S. / Busch, H. / Collins, C. / Chatham, W. / DeLaRosa, O. / Narvaez, M. / Hautamaki, E. / Gaylis, N. et al. | 2016
- A76
-
Sensitivity of Clinical Endpoints in the Asco Oncology Value Framework and Implications for Clinical Trial DesignChawla, A. / Wood, B. / Myrick, S. / Smith, G. / Chawla, V. / Doyle, J. et al. | 2016
- A76
-
Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Bilag-2004Collins, C. / Hautamaki, E. / Narayanan, S. / Busch, H. / Lamichhane, D. / Woodruff, L. / Gaylis, N. / Chatham, W. et al. | 2016
- A77
-
The Diffusion of Indirect Comparison Meta-Analytic Methods in the Study of Drugs: A Systematic Review and Co-Authorship Network AnalysisBan, J. / Tadrous, M. / Cicinelli, E. / Dubins, D. / Cadarette, S. et al. | 2016
- A77
-
Accounting for Rater Severity/Leniency in Endpoint Measures in Adults with Severe TBIMallinson, T. / Pape, T. / Guernon, A. et al. | 2016
- A77
-
A Case For Market-Based Costs In Determining Cost Effectiveness: The Hepatitis C ExampleLeinwand, B. / Hughes, K. E. / Sorenson, C. / Johnsrud, M. et al. | 2016
- A77
-
Latest Trends in Design of Pivotal Clinical Trials for Huntington’s DiseaseAggarwal, S. / Kumar, S. / Topaloglu, H. et al. | 2016
- A77
-
Economic And Productivity Consequences Associated With Rheumatoid Arthritis Among Non-Institutionalized Individuals In The United StatesGaitonde, P. / Shaya, F. T. et al. | 2016
- A78
-
Indirect Costs Calculation Method In Medium-Sized Regional HospitalKamensky, V. / Svoboda, V. / Simackova, J. / Rogalewicz, V. et al. | 2016
- A78
-
Are Current Cost-Utility Thresholds In China Useful?Sun, J. / Sun, L. et al. | 2016
- A78
-
Guidelines For Budget Impact Analysis: A Literature ReviewLuna, L. C. / Costa, M. G. / Tura, B. R. / Correia, M. G. / Santos, M. et al. | 2016
- A78
-
Developing Consistent Measures For Cost Analyses of Dementia Behavioral Trials: A Review Of Four Study ProtocolsVarga, S. / Prioli, K. / Gitlin, L. N. / Jutkowitz, E. / Pizzi, L. T. et al. | 2016
- A78
-
Evidence Gaps In Economic Evaluations For Non-Drug Technologies: A Canadian Cost PerspectiveBudden, A. J. / Tsoi, B. / Lee, K. et al. | 2016
- A78
-
Comparative Assessment of Cost Effectiveness of Operative Methods For Spinal Disc Herniation TreatmentSassykova, A. / Kulkhan, T. / Gurtskaya, G. / Mauyenova, D. / Saduakassova, L. / Yermakhanova, G. et al. | 2016
- A79
-
Value Assessment of Orphan Drugs For Treatment of Rare Diseases: A Systematic ReviewLockhart, C. M. / Hansen, R. N. et al. | 2016
- A79
-
Comparing Modeling Approaches In Cost-Effectiveness Analysis Using Secondary Survival Data: A Study of Nivolumab Versus Everolimus In The Treatment of Metastatic Renal Cell CarcinomaGrewal, S. et al. | 2016
- A79
-
Validation of A Cost-Effectiveness Model Comparing Accuracy of Genetic Tests For Brca MutationsBiltaji, E. / Bellows, B. / Stenehjem, D. / Brixner, D. et al. | 2016
- A79
-
Linkage Analysis of Multiple-Sclerosis Patient Data From Social-Media Surveys And Claims Databases Identifies A Representative Population For Real-Life Outcomes ResearchRisson, V. / Godge, B. / Bonzani, I. / Korn, J. R. / Medin, J. / Olson, M. S. et al. | 2016
- A79
-
Web-Based Budget Impact And Pricing Scenarios Planning Model: Example From The United KingdomRousseau, B. / Johnson, B. / Topachevskyi, O. / Volovyk, A. et al. | 2016
- A80
-
Expected Cost Estimation For Hospitalization In Patients Treated In A Colombian Insurance CompanyRomero, M. / Celis, S. / Acero, G. / Barrios, E. et al. | 2016
- A80
-
Identification Of Persons With Congenital Hemophilia In A Large Electronic Health Record DatabaseWang, M. / Cyhaniuk, A. / Cooper, D. L. / Iyer, N. N. et al. | 2016
- A80
-
Evaluating The Cost Effectiveness of Personalised Medicine Co-Dependent Technologies: A Conceptual FrameworkAkude, P. / Mahjoub, R. / McCabe, C. / Paulden, M. et al. | 2016
- A80
-
Use Of Databases For Health Resource Utilizaton And Cost Analyses In EU-5: Results From A Focused Literature ReviewDe Cock, E. / Cosmatos, I. / Kirsch, E. et al. | 2016
- A80
-
Value of Transferability And Efficiency In HTAZamora, B. / Marsden, G. / Towse, A. et al. | 2016
- A81
-
Development Of A Linked Database For Cystic Fibrosis Research By Integrating A Patient Registry With Administrative Claims DataJiao, T. / Biskupiak, J. E. / Ye, X. / Unni, S. / Dowd, C. / Fink, A. / Feng, L. / Erdo, J. / Brixner, D. et al. | 2016
- A81
-
LEVERAGING ELECTRONIC MEDICAL RECORD-BASED ANALYTICS TO OPTIMIZE THE DESIGN OF AN OBSERVATIONAL PROSPECTIVE STUDY OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASEWang, X. / Gerhardsson, M. / Sveréus, A. / Hiller, J. / Wong, D. / Nasuti, P. / Jenner, H. / Mckenney, A. / Kamauu, A. W. / Flickinger, K. M. et al. | 2016
- A81
-
QUANTIFYING THE DELAY TO FINAL ACCEPTANCE WITH EACH RESUBMISSION: ANALYSIS OF REAL-WORLD/HEALTH-ECONOMIC MANUSCRIPTSTruss, N. / Fuchsberger, M. / Streng-Ouwehand, I. / Nuottamo, N. / Polk, E. et al. | 2016
- A81
-
PATIENT-LED RESEARCH: CHARACTERIZING USE OF A NOVEL MEDICAL RECORD TECHNOLOGY AMONGST AN INFLAMMATORY BOWEL DISEASE COHORTBedenbaugh, A. / Soi, S. / Ahmed, E. et al. | 2016
- A81
-
DEVELOPMENT OF A NOVEL ADMINISTRATIVE CLAIMS-BASED ALGORITHM TO IDENTIFY LINES OF THERAPY AMONG MULTIPLE MYELOMA PATIENTS IN THE UNITED STATESKozma, C. M. / Slaton, T. / Macomson, B. / Maiese, E. M. et al. | 2016
- A82
-
ANALYSIS METHOD OF GOVERNMENT HEALTH CARE IN BRAZILIAN MUNICIPALITIES, USING PUBLIC AND OFFICIAL SOURCENita, M. E. / Mussolino, F. / Vaz, P. / Tolentino, A. C. / Riveros, B. S. et al. | 2016
- A82
-
IDENTIFYING BEST PRACTICES FOR USE OF TEXT DATA IN HEALTH ECONOMICS AND OUTCOMES RESEARCH USING NATURAL LANGUAGE PROCESSINGFeinberg, B. A. / Lal, L. / Garofalo, D. F. / Mujumdar, U. et al. | 2016
- A82
-
EVALUATION OF EUROPEAN ALZHEIMER’S DISEASE REAL-WORLD DATA SOURCES FOR FUTURE PHARMACOECONOMIC OR OUTCOMES RESEARCHLozano-Ortega, G. / Wang, S. / Chan, E. / Bosshard, R. et al. | 2016
- A82
-
PROBABILISTIC RECORD MATCHING USING MACHINE LEARNING TECHNIQUESRoss, J. M. / Fermin Cota, R. N. / Zaric, G. S. et al. | 2016
- A82
-
COMPARISON OF DATA TO DECISION MODELS FOR A DATA CONSORTIAKum, H. / Ohsfeldt, R. et al. | 2016
- A82
-
WHAT ARE PEER REVIEWERS LOOKING FOR IN REAL-WORLD/HEALTH ECONOMIC PAPERS? ASSESSMENT OF POSITIVE FEEDBACK FROM PEER-REVIEWER COMMENTSHartog, T. E. / Diamond, M. / Nuottamo, N. / Dekker, P. / Peters, K. et al. | 2016
- A83
-
VIRTUAL CONSULTATION SYSTEM: A WEB-BASED PLATFORM TO ASSESS COMPLEX CLINICAL CASES THROUGH SHARING OF DIAGNOSTIC IMAGES AND REPORTSSaraceno, D. / Ortali, M. / Covezzoli, A. / De Rosa, M. / Czauderna, P. et al. | 2016
- A83
-
EFFECTIVENESS AND SAFETY OF MACITENTAN IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONSimbaqueba, E. / Gomez, L. M. / Huerfano, C. / Tamayo, C. / Palomino, R. A. et al. | 2016
- A83
-
CURATING AN ELECTRONIC HEALTH RECORD RESEARCH QUERY DEFINITION LIBRARYLohnes, M. / Parker, C. / Kamauu, A. W. et al. | 2016
- A83
-
AN OPEN-SOURCE ANALYTIC VISUALIZATION PACKAGE FOR COMPLEX TREATMENT PATTERNS IN RWilson, J. B. / Korol, E. / Goring, S. J. / Tao, R. / Goring, S. et al. | 2016
- A83
-
INSIGHTS FOR CARE: BUILDING A PSEUDONYMISED, LINKED, CROSS-SETTING REAL-WORLD EVIDENCE LAB IN BIRMINGHAM, UNITED KINGDOMFoxcroft, R. / Chapman, D. / Yassa, L. / Bidgoli, F. / Cooke, M. / Bellary, S. / Ronte, H. et al. | 2016
- A83
-
USING READILY AVAILABLE ADMINISTRATIVE DATA ELEMENTS TO PREDICT FUTURE MEDICATION NON-ADHERENCE AMONG COPD PATIENTS WITH EMPLOYER-SPONSORED INSURANCEPatel, J. / Dalal, A. / Stanford, R. / Aparasu, R. / Abughosh, S. / Johnson, M. L. et al. | 2016
- A84
-
OPTIMIZATION OF THE GENERAL SURGERY SERVICE OF THE UNIVERSITY HOSPITAL PEDRO ERNESTOCunha, G. N. / Vianna, C. M. / Oliveira, F. S. / Mosegui, G. B. / Assumpcao, L. R. / Rodrigues, M. P. et al. | 2016
- A84
-
ASSESSMENT AND COMPARISON OF COMPETITIVENESS BETWEEN CLINICAL TRIAL PROTOCOLS: A PSEUDOPOPULATION MODEL AND SIMULATION APPROACHWilson, A. / Krikov, S. / Parker, C. / Kamauu, A. / Paredes, R. K. / Kamauu, A. W. et al. | 2016
- A84
-
THE DISTRIBUTION OF THE EQ-5D-5L INDEX IN PATIENTS POPULATIONSFeng, Y. / Devlin, N. / Bateman, A. / Zamora, B. / Parkin, D. et al. | 2016
- A84
-
IDENTIFYING THE CAUSES OF READMISSION AMONG DIABETIC PATIENTS USING MACHINE-LEARNINGKatsipis, I. et al. | 2016
- A84
-
ASSESSMENT OF THE IMPACT OF PRICE-VOLUME ADJUSTMENT PROGRAM ON PHARMACEUTICAL EXPENDITURE FOR DIABETES DRUGS: EVIDENCE IN SOUTH KOREAHan, E. / Park, S. / Myung, J. / Lee, E. et al. | 2016
- A85
-
THE EVOLUTION OF ECONOMIC MODELING IN ALZHEIMER’S DISEASE: WHERE DO WE GO FROM HERE?Hernandez, L. et al. | 2016
- A85
-
A NOVEL METHOD USING PRESCRIPTION TREATMENT PATTERNS TO ESTIMATE HEART FAILURE PREVALENCE IN CANADAJobin-Gervais, K. / Zaour, N. / Caron, J. / Borrelli, R. / Fischer, A. A. et al. | 2016
- A85
-
DELIVERING ACTIONABLE RESULTS FOR OBSERVATIONAL STUDIES THROUGH RAPID EVALUATION PROCESSESMack, C. / Parmenter, L. / Velentgas, P. / Franke, K. / Jablonski, R. / Dreyer, N. A. et al. | 2016
- A85
-
PROXY DEFINITIONS IN RETROSPECTIVE BURDEN OF ILLNESS STUDIES: A SYSTEMATIC REVIEWFrame, D. / Pilcher, L. / Wallace, E. et al. | 2016
- A85
-
IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATORTafazzoli, A. / DosSantos, R. / Ishak, K. J. / Krotneva, S. / Kansal, A. et al. | 2016
- A85
-
MODELING ECODEVELOPMENTAL CONTEXT OF STDS/HIV RISK AND PROTECTIVE BEHAVIORS AMONG AFRICAN AMERICAN ADOLESCENTSLi, Y. / Mgbere, O. / Abughosh, S. / Chen, H. / Cuccaro, P. / Essien, E. J. et al. | 2016
- A86
-
STRUCTURAL SENSITIVITY ANALYSES OF MORTALITY AND LOCATION OF CARE IN A SIMULATION OF ALZHEIMER’S DISEASEKansal, A. / DosSantos, R. / Tafazzoli, A. et al. | 2016
- A86
-
WHAT MAKES A GOOD ECONOMIC EVALUATION IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REVIEW OF REIMBURSEMENT SUBMISSIONS TO PCODR AND NICELi, C. M. / Risebrough, N. A. / Briggs, A. et al. | 2016
- A86
-
THE COMPARISON OF CARDIOVASCULAR INCIDENCE PREDICTIONS IN TYPE 1 DIABETES UTILIZING ALTERNATIVE RISK PREDICTION MODELSFoos, V. / Lamotte, M. / McEwan, P. et al. | 2016
- A86
-
CONTRASTING PREDICTIONS OF RENAL DECLINE BETWEEN THE ADPKD OUTCOMES MODEL AND MAYO CLINIC IMAGING CLASSIFICATION OF ADPKDMcEwan, P. / Bennett, H. / O’Reilly, K. / Robinson, P. et al. | 2016
- A86
-
PROJECTIONS FOR TOTAL JOINT ARTHROPLASTY DEMAND FOR THE NEXT GENERATIONOdum, S. M. / Van Doren, B. A. / Curtin, B. / Fehring, T. K. / Mason, J. B. et al. | 2016
- A87
-
COMPARING DIRECT AND INDIRECT COSTS OF TYPE 2 DIABETES ACROSS THREE AGE RANGES IN THE UNITED STATESFoos, V. / Lamotte, M. / McEwan, P. et al. | 2016
- A87
-
DISCRIMINATING AMONG HIGH-RISK HEART FAILURE PATIENTS USING CLUSTERINGHane, C. / Nori, V. S. / Rumanes, L. / Crown, W. / Dunlay, S. / Sangaralingham, L. R. et al. | 2016
- A87
-
ASSESSING THE IMPACT OF SIMULATED TIME HORIZON ON PREDICTED INCREMENTAL QUALITY ADJUSTED LIFE YEARS IN TYPE 2 DIABETESFoos, V. / Lamotte, M. / McEwan, P. et al. | 2016
- A87
-
USING TEXT NOTES FROM CALL CENTER DATA TO PREDICT HOSPITALIZATIONLorenzana, A. / Tyagi, M. / Wang, Q. C. / Chawla, R. / Nigam, S. et al. | 2016
- A87
-
IMAGINARY WORLDS: THE STATUS OF MODELED CLAIMS PUBLISHED IN VALUE IN HEALTH JANUARY 2015 TO DECEMBER 2015Langley, P. C. / Schommer, J. / Rhee, T. G. et al. | 2016
- A87
-
PHARMACOKINETIC ADHERENCE TO STATINSStauffer, M. E. / Morrison, A. / Kaufman, A. S. et al. | 2016
- A88
-
EXTERNAL VALIDATION OF HEALTH ECONOMIC MODELS FOR COMPLEX CHRONIC DISEASES: LESSONS FROM A POPULATION MODEL FOR DIABETIC RETINOPATHYHerring W., Mladsi D.M. , RTI Health Solutions, Research Triangle Park, NC, USA| 2016
- A88
-
QUANTIFYING THE HEALTH ECONOMIC BENEFIT OF KEY THERAPEUTIC OUTCOMES IN THE MANAGEMENT OF TYPE 2 DIABETES AND ASSESSING THEIR INTER-RELATIONAHIPMcEwan, P. / Foos, V. / Lamotte, M. / Evans, M. et al. | 2016
- A88
-
UPDATE OF THE MODEL VALIDATION OF THE ECONOMIC AND HEALTH OUTCOMES MODEL OF TYPE 2 DIABETES MELLITUS (ECHO-T2DM)Asseburg, C. / Willis, M. / Johansen, P. / Nilsson, A. / Neslusan, C. / Schroeder, M. et al. | 2016
- A88
-
PARAMETERIZATION OF A DISEASE PROGRESSION SIMULATION MODEL FOR SEQUENTIALLY TREATED METASTATIC HER2-POSITIVE BREAST CANCER PATIENTSAli, A. A. / Diaby, V. / Adunlin, G. / Kohn, C. G. / Montero, A. J. et al. | 2016
- A88
-
CAN HOLISTIC MCDA TACKLE ISSUES RAISED BY EVALUATING TREATMENTS FOR RARE DISEASES: AN EXPLORATION FROM THE HTA PERSPECTIVEGoetghebeur, M. M. / Wagner, M. / O’Neil, B. / Samaha, D. / Baltussen, R. et al. | 2016
- A88
-
ALTERNATIVE APPROACHES TO MODELLING HBA1C PROGRESSION IN TYPE 2 DIABETES AND THEIR IMPACT ON HEALTH ECONOMIC OUTCOMESMcEwan, P. / Bennett, H. / Fellows, J. / Yapp, R. / Bergenheim, K. / Qin, L. / Varol, N. / Gordon, J. et al. | 2016
- A89
-
HOSPITAL PERFORMANCE ON QUALITY MESAURES: APPROACHES TO FAIR CROSS-HOSPITAL COMPARISONS AND VALUE-BASED PAYMENTSNygren, K. / Suponcic, S. et al. | 2016
- A89
-
AN EXPLORATION OF THE HETEROGENEITY IN A NETWORK META-ANALYSIS EXPLAINED BY DOSING DIFFERENCESSchmitz, S. / Kandala, N. / Senn, S. et al. | 2016
- A89
-
IS EXENATIDE REALLY LINKED TO ACUTE PANCREATITIS: A NOVEL ANALYTIC EXAMINATION?Chen, J. / Hauptman, P. J. / Turner, J. S. / Burroughs, T. E. et al. | 2016
- A89
-
IMPACT OF IMPLEMENTING INTERNATIONAL REFERENCE PRICING ON PHARMACEUTICAL PRICES FOR UNITED STATES MEDICAREWeiss, J. / Hakim, P. / Degun, R. et al. | 2016
- A89
-
COMPARISON OF PROPENSITY SCORE WITH ZIP MODELS IN ANALYZING ZERO-INFLATED COUNT DATA IN OBSERVATIONAL STUDIESTu, C. / Koh, W. Y. et al. | 2016
- A89
-
MAPPING CANINE LEPTOSPIROSIS RISK IN THE UNITED STATESMwacalimba, K. K. / Wright, A. K. / White, A. / Zambrana-Torrelio, C. / Allen, C. / Rostal, M. / Ball, E. / Husain, I. / Karesh, W. B. / Daszak, P. et al. | 2016
- A90
-
QUANTIFYING AND ADJUSTING FOR EFFECT MODIFICATION IN INDIRECT TREATMENT COMPARISONSGoring, S. M. / Wilson, J. B. / Thompson, J. C. / Scott, D. A. et al. | 2016
- A90
-
COMPARING HOSPITAL PERFORMANCE FOR IN-HOSPITAL MORTALITY IN PNEUMONIA PATIENTS USING TRADITIONAL LOGISTIC REGRESSION AND MULTILEVEL MODELING APPROACHSura, S. D. / Bhansali, A. / Wang, X. / Johnson, M. L. / Aparasu, R. et al. | 2016
- A90
-
SURVIVAL NETWORK META-ANALYSIS: HAZARD RATIOS VERSUS RECONSTRUCTED SURVIVAL DATAVickers, A. D. et al. | 2016
- A90
-
ESTIMATION OF TRANSITION PROBABILITIES BETWEEN CERVICAL LESIONS FOR THE NATURAL HISTORY OF CERVICAL CANCER AMONG CHINESE WOMENWen, Y. / Chen, J. / Wang, Y. / Li, C. / Pan, X. / Yang, C. et al. | 2016
- A90
-
VALUE OF INFORMATION METHODS FOR OPTIMAL TIMING OF BIOMARKER COLLECTIONBansal, A. / Basu, A. et al. | 2016
- A91
-
AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATAEllis, A. G. / Dahabreh, I. / Wong, J. B. / Trikalinos, T. A. et al. | 2016
- A91
-
APPLICATION OF ITEM RESPONSE THEORY IN VALIDATING THE PATIENT HEALTH QUESTIONNARE (PHQ-9) IN THE AMERICAN GENERAL POPULATIONGupta, S. / Witt, E. A. et al. | 2016
- A91
-
DEVELOPING GRAPHICAL USER INTERFACE FOR BAYESIAN STATISTICS APPLIED TO MIXED TREATMENT COMPARISON ON R COMMANDERCorreia, M. G. / Tura, B. R. / Lanzillotti, R. S. et al. | 2016
- A91
-
PSYCHOMETRIC EVALUATION OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY–ANEMIA (FACT-AN) IN DIALYSIS AND NON-DIALYSIS PATIENTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASEvan Nooten, F. E. / Wiklund, I. / Trundell, D. / Cella, D. et al. | 2016
- A91
-
ESTIMATION OF TRANSITION PROBABILITIES BETWEEN ESOPHAGEAL CANCER AND ITS PRECANCEROUS LESIONS BASED ON A MARKOV MODELChen, J. / Wang, Y. / Li, C. / Wen, Y. / Pan, X. / Yang, C. et al. | 2016